var title_f12_47_13040="Listeria monocytogenes in CSF";
var content_f12_47_13040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Listeria monocytogenes in cerebrospinal fluid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gram stain of cerebrospinal fluid (x1000) shows inflammatory cells and small, gram-positive rods and coccobacilli. Culture of this specimen revealed moderate-sized, beta-hemolytic colonies composed of small, motile gram-positive rods, confirmed to be",
"    <em>",
"     Listeria monocytogenes",
"    </em>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13040=[""].join("\n");
var outline_f12_47_13040=null;
var title_f12_47_13041="Contents: Reproductive endocrine female";
var content_f12_47_13041=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?6/40/6798\">",
"       Obstetrics, Gynecology and Women's Health",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Reproductive endocrine female",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Reproductive endocrine female",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Contraception",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/13/42201\">",
"           Contraception: Overview of issues specific to adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/54/33640\">",
"           Contraceptive vaginal ring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/5/31833\">",
"           Emergency contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/24/39306\">",
"           Overview of contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/19/32058\">",
"           Overview of intrauterine contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/5/18522\">",
"           Overview of the use of estrogen-progestin contraceptives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/7/39034\">",
"           Risks and side effects associated with estrogen-progestin contraceptives",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endometriosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/46/5863\">",
"           Diagnosis and management of ovarian endometriomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/8/11402\">",
"           Diagnosis and treatment of endometriosis in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/35/8761\">",
"           Gonadotropin releasing hormone agonists for long-term treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/15/38136\">",
"           Pathogenesis and treatment of infertility in women with endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19210\">",
"           Pathogenesis, clinical features, and diagnosis of endometriosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Estrogen replacement therapy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/34/40486\">",
"           Continuous postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/63/41975\">",
"           Estrogen and cognitive function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/38/41576\">",
"           Managing the side effects of tamoxifen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/2/7210\">",
"           Mechanisms of action of selective estrogen receptor modulators",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/44/41672\">",
"           Molecular biology and physiology of estrogen action",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/36/29258\">",
"           Postmenopausal hormone therapy and cardiovascular risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/11/11449\">",
"           Postmenopausal hormone therapy and the risk of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/26/17831\">",
"           Postmenopausal hormone therapy in the prevention and treatment of osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/23/32122\">",
"           Postmenopausal hormone therapy: Benefits and risks",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/53/16218\">",
"           Preparations for postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/42/40615\">",
"           Treatment of menopausal symptoms with hormone therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fertility",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/18/3367\">",
"           Causes of female infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/41/35479\">",
"           Classification and treatment of ovarian hyperstimulation syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/10/11433\">",
"           Donor insemination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/7/38010\">",
"           Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/61/18392\">",
"           Fertility preserving options for women of advancing age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/35/8761\">",
"           Gonadotropin releasing hormone agonists for long-term treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/56/37770\">",
"           In vitro fertilization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/11/15546\">",
"           Intracytoplasmic sperm injection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/31/26101\">",
"           Intrauterine adhesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/14/24807\">",
"           Oocyte donation for assisted reproduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/13/11482\">",
"           Optimizing natural fertility in couples planning pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/56/17287\">",
"           Overview of infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/10/13482\">",
"           Overview of ovulation induction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/6/4201\">",
"           Ovulation induction with aromatase inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/25/9626\">",
"           Ovulation induction with clomiphene citrate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/15/38136\">",
"           Pathogenesis and treatment of infertility in women with endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/17/16660\">",
"           Pathogenesis of ovarian hyperstimulation syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19210\">",
"           Pathogenesis, clinical features, and diagnosis of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/42/36519\">",
"           Posthumous assisted reproduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/7/22647\">",
"           Prevention of ovarian hyperstimulation syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/48/25351\">",
"           Procedure for intrauterine insemination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/18/9513\">",
"           Reproductive surgery for female infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/6/16487\">",
"           Strategies for improving the efficacy of clomiphene induction of ovulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/27/43449\">",
"           Strategies to control the rate of high order multiple gestation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/42/15015\">",
"           Surrogate pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/36/29256\">",
"           Techniques for preimplantation sex selection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/57/25496\">",
"           Unexplained infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/59/39865\">",
"           Use of assisted reproduction in HIV and hepatitis infected couples",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hormone physiology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/2/7210\">",
"           Mechanisms of action of selective estrogen receptor modulators",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/44/41672\">",
"           Molecular biology and physiology of estrogen action",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/47/8952\">",
"           Pharmacology and mechanism of action of progesterone receptor modulators (PRMs)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/27/32181\">",
"           Physiology of gonadotropin-releasing hormone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/16/25866\">",
"           Therapeutic use and adverse effects of progesterone receptor antagonists and selective progesterone receptor modulators",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hyperandrogenism and hirsutism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/31/9721\">",
"           Evaluation of premenopausal women with hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/48/38662\">",
"           Ovarian hyperthecosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/28/24007\">",
"           Pathogenesis and causes of hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/37/35416\">",
"           Treatment of hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/16/32005\">",
"           Use of GnRH agonists in the treatment of hyperandrogenism and hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/17/27928\">",
"           Use of combination estrogen-progestin contraceptives in the treatment of hyperandrogenism and hirsutism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypogonadism and ovarian failure",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/42/33449\">",
"           Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/2/36903\">",
"           Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/7/2170\">",
"           Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/2/2089\">",
"           Etiology, diagnosis, and treatment of primary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/56/34697\">",
"           Etiology, diagnosis, and treatment of secondary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/63/14329\">",
"           Management of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/63/37880\">",
"           Management of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/22/15720\">",
"           Ovarian development and failure (menopause) in normal women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/26/1447\">",
"           Ovarian failure due to anticancer drugs and radiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/40/7817\">",
"           Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/26/23976\">",
"           Pathogenesis, diagnosis, and treatment of autoimmune ovarian failure",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Menopause",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/45/20184\">",
"           Androgen production and therapy in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/45/44761\">",
"           Clinical manifestations and diagnosis of menopause",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/34/40486\">",
"           Continuous postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/38/41576\">",
"           Managing the side effects of tamoxifen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/53/25434\">",
"           Menopausal hot flashes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/53/16218\">",
"           Preparations for postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/42/40615\">",
"           Treatment of menopausal symptoms with hormone therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Menstrual cycle",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/3/36919\">",
"           Amenorrhea and infertility associated with exercise",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/7/31866\">",
"           An overview of endometrial ablation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/41/20122\">",
"           Chronic menorrhagia or anovulatory uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/52/39751\">",
"           Clinical manifestations and diagnosis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/16/28935\">",
"           Epidemiology and pathogenesis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/6/26724\">",
"           Evaluation of the menstrual cycle and timing of ovulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/2/27685\">",
"           Physiology of the normal menstrual cycle",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/25/31125\">",
"           Primary dysmenorrhea in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/10/3241\">",
"           Treatment of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/8/44166\">",
"           Ultrasound evaluation of the normal menstrual cycle",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/61/22489\">",
"           Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/31/23034\">",
"           Clinical manifestations of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/5/19546\">",
"           Definition, etiology, and evaluation of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27096\">",
"           Diagnosis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/16/41220\">",
"           Normal sexual differentiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19210\">",
"           Pathogenesis, clinical features, and diagnosis of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/25/31125\">",
"           Primary dysmenorrhea in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/36/2630\">",
"           Transsexualism: Epidemiology, pathophysiology, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/41/8857\">",
"           Treatment of gonadotroph and other clinically nonfunctioning adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/52/31561\">",
"           Treatment of hyperprolactinemia due to lactotroph adenoma and other causes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/49/4889\">",
"           Treatment of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/25/8602\">",
"           Treatment of transsexualism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pediatric issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/25/31125\">",
"           Primary dysmenorrhea in adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Polycystic ovary syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/6/16490\">",
"           Clinical manifestations of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/36/39495\">",
"           Diagnosis of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/39/40568\">",
"           Epidemiology and pathogenesis of the polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/0/24583\">",
"           Laparoscopic surgery for ovulation induction in polycystic ovary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/27/16826\">",
"           Metformin for treatment of the polycystic ovary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/0/12\">",
"           Steroid hormone metabolism in polycystic ovary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/46/24297\">",
"           Treatment of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/49/1817\">",
"           Treatment of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/61/35798\">",
"           Androgen production and metabolism in normal pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/32/1543\">",
"           Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/2/18470\">",
"           Causes of gestational hyperandrogenism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/32/31236\">",
"           Diagnosis and management of gestational hyperandrogenism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/34/29226\">",
"           Management of asthma during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/7/13434\">",
"           Management of hypertension in pregnant and postpartum women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/34/41510\">",
"           Management of lactotroph adenoma (prolactinoma) during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/61/34777\">",
"           Pathogenesis of preeclampsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/45/19159\">",
"           Physiology and clinical course of asthma in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/20/27978\">",
"           Preeclampsia: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/62/11241\">",
"           Pregnancy in women with underlying renal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/40/41609\">",
"           Prevention of preeclampsia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Puberty",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/13/39130\">",
"           Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/5/19546\">",
"           Definition, etiology, and evaluation of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/9/34970\">",
"           Definition, pathogenesis, and etiology of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/11/12473\">",
"           Diagnosis and management of congenital anomalies of the vagina",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/25/1434\">",
"           Normal puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/62/21481\">",
"           Premature adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/46/24297\">",
"           Treatment of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/49/4889\">",
"           Treatment of precocious puberty",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sexual dysfunction",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/40/36484\">",
"           Reproductive and sexual dysfunction in uremic women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/15/8442\">",
"           Sexual activity in patients with heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/42/25258\">",
"           Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/10/34985\">",
"           Sexual dysfunction in women: Management",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-2A82FD7A42-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f12_47_13041=[""].join("\n");
var outline_f12_47_13041=null;
var title_f12_47_13042="Abdominal CT scan showing superior mesenteric artery syndrome";
var content_f12_47_13042=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F76655&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F76655&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 570px\">",
"   <div class=\"ttl\">",
"    Abdominal CT scan showing superior mesenteric artery syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 550px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomography of the abdomen with intravenous contrast showing a narrowed angle between the superior mesenteric artery and the aorta measuring eight degrees.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Abu-Zidan FM, Hefny AF, Saadeldinn YA, El-Ashaal YI. Sonographic findings of superior mesenteric artery syndrome causing massive gastric dilatation in a young healthy girl. Singapore Med J 2010; 51:e184. Copyright &copy; 2010 Singapore Medical Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13042=[""].join("\n");
var outline_f12_47_13042=null;
var title_f12_47_13043="Placement of laparoscopic instruments for total colectomy";
var content_f12_47_13043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F83873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F83873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Placement of laparoscopic instruments for total colectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows the placement of the laparoscopic instruments in preparation for performing a total colectomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13043=[""].join("\n");
var outline_f12_47_13043=null;
var title_f12_47_13044="Hair entrapment removal techniques";
var content_f12_47_13044=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hair entrapment removal techniques",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13044/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13044/contributors\">",
"     Joan Bothner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13044/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13044/contributors\">",
"     Anne M Stack, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13044/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13044/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/47/13044/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hair or thread tourniquet syndrome is the term used to describe the clinical entity caused by a hair or thread becoming tightly wrapped around an appendage. The proposed mechanism is repetitive movement of the appendage in a confined area (eg, mittens or feet-in pajamas), with resultant wrapping of the offending fiber or hair around the digit. This leads to constriction of the digit, impedance of lymphatic and venous drainage, swelling, edema, and eventual ischemia. With progressive swelling, the constricting agent may become embedded in the soft tissue or cut through the skin. Hair stretches when wet, and can be wound loosely around an appendage, but will become constrictive as it dries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one review of 66 cases of hair or thread tourniquet syndrome in children, 43 percent involved the toes, 24 percent the fingers, and 33 percent the external genitalia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among the children with toe involvement, the median age was four months (range three weeks to 15 months) and hair was the cause of strangulation in 79 percent (",
"      <a class=\"graphic graphic_picture graphicRef50150 \" href=\"UTD.htm?5/7/5233\">",
"       picture 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/1\">",
"       1",
"      </a>",
"      ]. This age range has been reported to coincide with maternal telogen effluvium (postpartum hair loss, seen in 90 percent of mothers). Thus, new mothers should be counseled regarding the possibility of hair tourniquets in infants [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among the children with finger involvement, the median age was three weeks (range four days to 19 months) and fiber or thread was the cause of strangulation in 88 percent. This suggests that finger injuries may be related to the use of mittens to prevent scratching of the face by the fingernails in very young infants.",
"     </li>",
"     <li>",
"      Among the children with involvement of the external genitalia, the median age was two years (range four months to six years), most cases involved circumcised boys, and all but one case involved injuries to the penis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/1,3\">",
"       1,3",
"      </a>",
"      ]. Rarely, hair tourniquets may involve the clitoris, labia majora, or labia minora in older girls, including adolescents [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/4-7\">",
"       4-7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Strangulation injuries of the external genitalia in young children may occur during diaper change or bathing. In addition, strangulation injuries of the penis have been associated with attempts to control nocturnal enuresis (by wrapping the penis). Strangulation injuries of the clitoris among older girls (8 to 11 years of age) may be self-inflicted [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/4,8\">",
"     4,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Strangulation injuries of the digits are usually considered to be unintentional. However, strangulation injuries of the genitalia should raise the question of child abuse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of hair or thread tourniquet syndrome can usually be made by history and physical examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of hair-thread tourniquet syndrome are often nonspecific. They include unexplained irritability or crying and penile or clitoral pain or swelling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants who present with fussiness or irritability should be carefully examined for evidence of a hair or thread tourniquet. Physical examination findings may include swelling or redness of the digits or genitalia. Swelling or reepithelialization can obscure or hide the strand, making the diagnosis more difficult.",
"   </p>",
"   <p>",
"    The digits and genitalia should be carefully inspected for a circumferential band proximal to the swelling. Magnification can help to differentiate nonspecific swelling from a hair or fiber tourniquet [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of digit swelling includes secondary swelling from insect bite or sting, allergic reaction or contact dermatitis, and strangulation injury. The differential diagnosis of penile swelling in a prepubertal child includes balanitis; paraphimosis; trauma; secondary swelling from an insect bite or sting, allergic reaction, or contact dermatitis; and strangulation injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of a hair or string tourniquet depends upon the extent of damage to the appendage and the depth of the fiber or hair. Hair usually penetrates less deeply and can be more easily found on the dorsal surface of fingers or toes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18434003\">",
"    <span class=\"h2\">",
"     Superficial hair or thread",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the hair or thread is superficially embedded, options for removal include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Grasping the loose end of the fiber (if one can be found) with fine forceps or a hemostat and unwinding it from the appendage.",
"     </li>",
"     <li>",
"      Carefully inserting a blunt probe or curette under the hair (or thread) to isolate it, and then cutting the fiber with scissors or a scalpel.",
"     </li>",
"     <li>",
"      Using chemical hair removers to dissolve the offending hair [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/10\">",
"       10",
"      </a>",
"      ]. This approach is described in anecdotal reports and has not been scientifically evaluated. If tried, it should be reserved for injuries that have no associated skin breakdown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After the hair is successfully removed, the area should be carefully explored for additional strands. Neurovascular and motor function should be tested.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18434010\">",
"    <span class=\"h2\">",
"     Embedded hair or thread",
"    </span>",
"    &nbsp;&mdash;&nbsp;Removal of the tourniquet is more difficult if the hair has caused significant edema or has penetrated into the soft tissue. In this situation, direct incision of the constricting band is necessary to ensure release of the constriction, and surgical consultation is recommended. Urology consultation should be obtained before attempting an incisional approach for constricting bands of the penis.",
"   </p>",
"   <p>",
"    The child may require sedation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    local anesthesia before removal of the tourniquet. Local anesthesia, if necessary, can be achieved with a digital or dorsal penile block (",
"    <a class=\"graphic graphic_figure graphicRef79052 \" href=\"UTD.htm?31/12/31938\">",
"     figure 1",
"    </a>",
"    ) for digital and penile injuries, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/9/23703?source=see_link&amp;anchor=H12#H12\">",
"     \"Digital nerve block\", section on 'Digital block procedures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30100?source=see_link&amp;anchor=H2311462#H2311462\">",
"     \"Management of zipper injuries\", section on 'Dorsal penile block'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When incising the constricting band on the digits, the neurovascular bundles can be avoided by choosing the 3 o'clock or 9 o'clock position (",
"    <a class=\"graphic graphic_figure graphicRef79634 \" href=\"UTD.htm?42/2/43040\">",
"     figure 2",
"    </a>",
"    ). The incision should be made longitudinally in the proximal to distal direction with the scalpel blade perpendicular to the surface of the skin. To ensure that the hair is cut completely, the incision should be to the depth of bone.",
"   </p>",
"   <p>",
"    Alternatively, an incision can be made in the dorsal surface of the digit, completely avoiding the neurovascular bundles [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/11\">",
"     11",
"    </a>",
"    ]. The disadvantage to this approach is the possibility of injury to the extensor tendon. However, a longitudinal incision parallel to the length of the tendon is expected to heal well without long-term sequelae.",
"   </p>",
"   <p>",
"    Reperfusion is usually evident within a few minutes of release of constriction. Depending upon the degree of soft tissue injury, however, normal perfusion may not return for several days. Surgical consultation is warranted if there is any question about complete transection of the constricting band.",
"   </p>",
"   <p>",
"    After incision, neurovascular and motor (tendon) function should be evaluated. The digit should be reevaluated 24 hours later to assess return of normal perfusion. It should be elevated as much as possible during the intervening 24 hours. Prophylactic antibiotics are not necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of hair tourniquet syndrome include ischemia and soft tissue injury. Damage to neurovascular structures can be caused by ischemia, the cutting action of the hair tourniquet, or incision of the constricting band. Infection is unusual, but can occur. Ischemia or injuries to the corpus cavernosum, corpus spongiosum, and urethra may occur with penile involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13044/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18433820\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hair or thread tourniquet syndrome is the term used to describe the clinical entity caused by a hair or thread becoming tightly wrapped around an appendage, most commonly a toe in a young infant. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physical findings include irritability, swelling of the involved appendage (digit or genitalia), and visualization of the constricting hair or thread. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When the hair or thread is superficially embedded, options for removal include (see",
"      <a class=\"local\" href=\"#H18434003\">",
"       'Superficial hair or thread'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Grasping the loose end of the fiber (if one can be found) with fine forceps or a hemostat and unwinding it from the appendage.",
"     </li>",
"     <li>",
"      Carefully inserting a blunt probe or curette under the hair (or thread) to isolate it, and then cutting the fiber with scissors or a scalpel.",
"     </li>",
"     <li>",
"      Using chemical hair removers to dissolve the offending hair. This approach is described in anecdotal reports and has not been scientifically evaluated. If tried, it should be reserved for injuries that have no associated skin breakdown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the hair has caused significant edema or has penetrated into the soft tissue, direct incision of the constricting band is necessary to ensure release of the constriction, and surgical consultation is recommended. Urology consultation should be obtained before attempting an incisional approach for constricting bands of the penis. (See",
"      <a class=\"local\" href=\"#H18434010\">",
"       'Embedded hair or thread'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The child may require sedation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      local anesthesia before removal of an embedded hair or thread tourniquet. Local anesthesia, if necessary, can be achieved with a digital or dorsal penile block (",
"      <a class=\"graphic graphic_figure graphicRef79052 \" href=\"UTD.htm?31/12/31938\">",
"       figure 1",
"      </a>",
"      ) for digital and penile injuries, respectively. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=see_link\">",
"       \"Procedural sedation in children outside of the operating room\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/9/23703?source=see_link&amp;anchor=H12#H12\">",
"       \"Digital nerve block\", section on 'Digital block procedures'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30100?source=see_link&amp;anchor=H2311462#H2311462\">",
"       \"Management of zipper injuries\", section on 'Dorsal penile block'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When incising the constricting band on the digits, the neurovascular bundles can be avoided by choosing the 3 o'clock or 9 o'clock position (",
"      <a class=\"graphic graphic_figure graphicRef79634 \" href=\"UTD.htm?42/2/43040\">",
"       figure 2",
"      </a>",
"      ). Alternatively, an incision can be made in the dorsal surface of the digit, completely avoiding the neurovascular bundles. (See",
"      <a class=\"local\" href=\"#H18434010\">",
"       'Embedded hair or thread'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reperfusion is usually evident within a few minutes of release of constriction. Depending upon the degree of soft tissue injury, however, normal perfusion may not return for several days. Surgical consultation is warranted if there is any question about complete transection of the constricting band. (See",
"      <a class=\"local\" href=\"#H18434010\">",
"       'Embedded hair or thread'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The digit should be reevaluated 24 hours later to assess return of normal perfusion. It should be elevated as much as possible during the intervening 24 hours. Prophylactic antibiotics are not necessary. (See",
"      <a class=\"local\" href=\"#H18434010\">",
"       'Embedded hair or thread'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/1\">",
"      Barton DJ, Sloan GM, Nichter LS, Reinisch JF. Hair-thread tourniquet syndrome . Pediatrics 1988; 82:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/2\">",
"      Strahlman RS. Toe tourniquet syndrome in association with maternal hair loss. Pediatrics 2003; 111:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/3\">",
"      Badawy H, Soliman A, Ouf A, et al. Progressive hair coil penile tourniquet syndrome: multicenter experience with 25 cases. J Pediatr Surg 2010; 45:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/4\">",
"      Kuo JH, Smith LM, Berkowitz CD. A hair tourniquet resulting in strangulation and amputation of the clitoris. Obstet Gynecol 2002; 99:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/5\">",
"      Stock C, Wang LC, Spigland NA. Untangling a web: an unusual case of labial necrosis in an adolescent female. J Pediatr Adolesc Gynecol 2012; 25:e21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/6\">",
"      Bacon JL, Burgis JT. Hair thread tourniquet syndrome in adolescents: a presentation and review of the literature. J Pediatr Adolesc Gynecol 2005; 18:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/7\">",
"      Pomeranz M, Schachter B, Capua T, Beyth Y. Hair-thread tourniquet syndrome of labia minor. J Pediatr Adolesc Gynecol 2009; 22:e111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/8\">",
"      Sylwestrzak MS, Fischer BF, Fischer H. Recurrent clitoral tourniquet syndrome. Pediatrics 2000; 105:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/9\">",
"      Pantuck AJ, Kraus SL, Barone JG. Hair strangulation injury of the penis. Pediatr Emerg Care 1997; 13:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13044/abstract/10\">",
"      O'Gorman A, Ratnapalan S. Hair tourniquet management. Pediatr Emerg Care 2011; 27:203.",
"     </a>",
"    </li>",
"    <li>",
"     Loiselle J, Cronan KM. Hair tourniquet removal. In: Textbook of Pediatric Emergency Procedures, 2nd, Henretig FM, King C.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6318 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.69.132.100-BE5EBB4FC7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13044=[""].join("\n");
var outline_f12_47_13044=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18433820\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18434003\">",
"      Superficial hair or thread",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18434010\">",
"      Embedded hair or thread",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18433820\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6318\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6318|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/12/31938\" title=\"figure 1\">",
"      Dorsal penile block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/2/43040\" title=\"figure 2\">",
"      Digital hair tourniquet removal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6318|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/7/5233\" title=\"picture 1\">",
"      Hair tourniquet syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/9/23703?source=related_link\">",
"      Digital nerve block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30100?source=related_link\">",
"      Management of zipper injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_47_13045="Benign patterns calcifica";
var content_f12_47_13045=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F75088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F75088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Benign patterns of calcifications",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 294px; height: 603px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vascular calcifications are seen in the lateral aspect of the breast on a CC mammogram (Panel A). Multiple coarse \"popcorn\" calcifications are characteristic features of calcifying fibroadenomas (Panel B). Bilateral benign secretory calcifications are seen in CC views of both breasts (Panels C and D). The cigar or rod shape is better seen on the magnification view (Panel E).",
"    <div class=\"footnotes\">",
"     CC: craniocaudal.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13045=[""].join("\n");
var outline_f12_47_13045=null;
var title_f12_47_13046="Hypersegmented neutrophil";
var content_f12_47_13046=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F70609&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F70609&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypersegmented neutrophil in megaloblastic anemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blood smear from a patient with megaloblastic anemia showing a neutrophil with an increased number of nuclear lobes. At least six discrete lobes are present; normal neutrophils have five lobes or fewer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen A. Landaw, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEBAYkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDuU8O+KXkMf9lhT03NKAv510nhbwR9lvo7/XJ47q6hb91bRf6uN/Uk/eI/Ku1YjHfHrnvSxH5wBj6Vw3tsdU8VOatscb418WXdnff2bopQT4zNORu2k/wj3ri44r/zDO17dGcnJfzDnNFoTPqV1I5JeSdyT9Ca7vS9NtZrQF9oc+/SjVHV7lCKVjI8OeL7zT7tLbXJWuLKVgomf78JPqe4r0dvl46+9eR+IYI1eRAAQMg16H4VuJLjwtpMs2S7QKCx744BpvVXObE04pKcdLmoXY7dqjGed3YetLnnPam5+b3xRk9ME1Byjs9M4I7Uue/600kY9jRuwTzz6etIQo6kDJFH0I644ppbkZy39KRm5weB1oGP4IPHTig4VSScCkHoKUkFSCAQe3rQA4gHkdOtVtSsLLVLYwajbR3ER5AYcr9D2qxyAQQAB0x6UhPGRTQJtao5M/D7Qd28m9EZ52eccD2re0jSdP0aAxaXarCCeX6sx9z1q5kdM9RnrTvupvkZUA/iJwKdzSVWclaTExkDP86OppI3jmyYpY5QBzsYGklkjt4pZp22xxIXc+wpWZmEm2JTJM6xxj+J2AFRWt5ZXRKWt7bzMD91JAa8j1HULnxFdtdXru0TH9zADhY17cetINI+QPHGUI6MmVI/GqstjtWDsvedmesa2JF0LUwmRL9mfb65wa8d0tlSzgwMqyKoP4V23gXxLOb1NG1Z/OWQEW8zD5iR1Rq5vxLpM3hfU5FCMdKlYtbyjomeqN6Y7UrGmHTpt05bnpljcaXDosbQyRraKm0pxknvkV5fqhjImIwqZYgHsO36VF9uTafnG3r97inaVp9z4mvltLEN9kyBc3OPljXuAe7EdBRYunS9leTZ6P4GLjwbo5kzu8njP93PH6Yqv4y8MHXdl5YukOqQjYpb7sq/3W/xroUSOGKKGEbIYlEaKOwAwBSjA/i56gZ60N6nnqo4z54njM0WqWEzR3um3iSA/wAKblJ9iOtXNO0HXNclCQ20tjb5+e6uBjA77V7mvXvMIHDnjtSbyTlmNCZ0PGytotTN0+203wxoIijdYdPtgXeWQ8s3die5Nc7cfEi0Rithptzcx/8APR8IGH0qh8U7h5dT03TM4tkia5Zf7z5wM/TNc7Bb7toXufz9qd7F0aEZx9pU1udIut+DdYmC6vpQspifvvHhf++hXX6ToukaUqy6TZWyBxlZl+YkeoNebXmi3MduGubd0jI6MOD71Z8Ga1LoOqRWFy7Npdy2xQxz5DnoR7Hpii9x1aV4/u5P0PTycnJPUUAcgdwKZcyR2sU01y4jghUu7noAO9ecan451PUGxoyCxtM/LI67pXHrjoKVjjpUZVfhPSmVghJBwPavNPi4u3XNEc58trd1X0zmqEPibxHayLIb1bll6LMnBHfpW9JcQ/ETQZ7Py1stdsT5sIJyM+oP909DVJHVToyoTU5bD/B0Vu9u5Z1VsDb6k0eK7aBNP3koJt2AB3FefW2o3OnXJhuVktLuM7Wjfgg+3rUmo680yk3M27PQdSTSOn6vJz5k9CzoW4eNNE8rcHNwPu+nevai5W4JGPvV4wv9o+D9DuPGFzpsk10q+VZ2zDiEN1mlxyB2wPUdOtd54D8Y2HjDSRdWZ8q5jwLi2Jy0Tf1U9j/XIrr+oV3hvrajeF7X7Pz7HBjMRTlW9knqkZPjDwRcz6jNqvh5o2eY7prRjgM395T2PtXO2+k+IN2x9GukI4J4r13JB4zThI5P3jkHHWuLcuGLnGPK9Tx7V0uYdZlju4Xhby0ZQ/8AdAx+Wa67SNDhk8NvIrB7x+SQeFHpTviZpVxc21tq1mrPJaArKg6mP1/Cua0HxBNawYhYNE3TJ6U7HTzSq004bkksEloSkqED17Vl6y2LcuOCrBh25BFa1/qzXEbI21c881n6LYv4i16CxiBa1hYTXcnZVB4H1JoS1NYtpc0j1qBy9nas+dzRKTntxS4Hq3506QhpDgfJjCjPQU3I9T+VTqeQ9S8qsxwoYkDdwtG1kYEggjnnivJ7i91e9cvdancluu1H2KPoBU2n+INa0tgVunu4R96C4O7I9j1FaWXc6PqkraMTxlpr6Lr01ysZGn3jeYkgGVR/4lPpzyKZbazti+V+PXNekaTqNlr+lefCivC3yTW8oyUbupFVf+ES8PtJ5h0uDPoM4/Kltoy1iVblqLVHnFra3PiTUBZWeck/vpf4Y07kn1x0FejeIta0/wALabbxlC7hBHa2sZ+ZgBjJ9B71r2Vrb2kawWUEdvET92MY/OvINduX1TxbqV05LLHMbeIHoEXjj8cn8aExxaxM9dIou3HjLxJcuWjnt7Re0cUQb9Tmrmn+O9Rs5ANahivLb+KWJNsij6dDj04qbQdCW/t5HeQRheBisvWdNFo7L/D2NHMaqNGT5LHp8N1b3NpHd20qSWsyhkkB4PoPrUw4HYfhXmnw2vDba6dMmIMUyPLb5P8Aq5ON2PqMV6QoCgY/L0pSVtjhrU/ZS5RScdcAUAhnKAgleo9PrQgJfgDd6+3vXCa/49dLt7Xw9DHMUOHu5RlCe4Ud6SVxU6UqjtE7tCG+dRwO5GDwcU4t279eK8ri8ZeJY33vc28w7o0IAPtXYeF/FcGuS/ZpY/seogZ8k8rKO5U/0p8vY0qYacFd7HSk8ctSHoc8UjNx056Usa73Cjj8ak5zI8Sa9DoNqjFPOvp8+TAO/wDtH0Fed373urS+fqlw8zE5CZwi+wFT6jeHWPEd5escxhzDD6CNTj/69dZo2kwNbrJMgckcKe4qz0IqNCKb3OE+xfZts9u7W8inCOjbTn2rstG1O58T+FNY0u6YHUooSu9RjzFI4P17Gm+KLCC3KtbjarDheuKzPAZaPxpmMkI1q3mY6Yzxn8acX0ZU2qlPn6rU5/QJA6wFlIwArDHQjgj8K9JjFuNLUMV27flx61g+LvDEkU8mq6LGzl23XFsnc92X+ormRrbxKYpi8TDjEgIIpBJe3SlFk2qSC21a0ngOHjuIypHruFeuXgR/MilRZI3yCjDIP1ry3wjpcmv6zFdyxyDTbRxK7sMea4+6g9eeTXp0h3uzEkZ60nsYYpq6XVGMfCXh5pPMbSbctnODnH5ZrYgjjghWG3jSOFeiIMAfhTh796TPHX3pHM5yluxRye/1pf8AOaY5WOIySMscS9WY4ArOXxHoZnMX9rW3mD34/OmlcSi3saoOOKTOBycf1oVlkiWSF1kibo6HI/OkIBIJGdvIOO/rSEcX8ULFmgs9XiUkWuYZ9o+6jd/wOKwdCu47W/triUB0VgzDrn3r1FlR4njmUPEylXQjIIPY155rfgy+sJWm0D/SrM8/ZmP7yP2U9xTO3D1YuPs5Ox1uoazp1zaMd6sGB+XqRXlPiKSPyJZEypU7wfcdKfLc3EBMU9ndRyZwVaM5zWloHhe+167il1GCS00mNg7mXh58HIUD0z1NB0U6caCcm9DpfiTqEi+FNMteQ+osglPT5QASPzxWL4V0+K/n8tyQoHQCun+Ielvq/h9p7dSbqwbzo0H8S9GX8q4nw1q/2WVJ4iSjDkdx7U27kUNaLUNzqdY8Pwx2BeBmMijkEVwjXMuk6vZ6jauUlilAYj+JScEH1rudV8TrJZyRQgfOMFj2HtXCmBtW1ew063JMtxMucc4QHLH8qS0NKHNyv2mx7HrGn6fqo2alZQXcZ+ZfMXJGR2PaqGm+HtF0ufzrDS7aKb/noRuYfTPStaQgSfIPkXCjnsOKIl8yVVPdsZ9qR5qnJKyehn69qenaVpsl1rsyJbSZj2MNzTE/whe/+c180Xd3ceE/FT+IfCcE1rYFz/o8xDgITyjY6qe3ccc5ANdp4o1KbxH4svLmQ/uLeRra2jPREU4JHuazNfTUrXTX/s/SFvomXDtndtHug5b8K93IsZVw+J9jBKUZ6SjJpJr56X7dfyLxWApfV+eo2pLVNdPu/E19Z+Non0O3lsdPFteNcRlgJQ2EUhnHTuPlz6N617NazRXVrBdWsnmwXEayxSDoysMg/lXxHICJGyuw5+76e3NfSn7PmtvqfgubTpW3zaZMEQk9I3BKj8w1fRcS8OUcBgo18MtpO/pLb7tF8zxMHjZVqrjPt+X+e56ip2jjBB6iuV1bwTY3s0ktrK9jcOxbMSjYc+q1u3+pWWnKZL2dExxgnms6w8R2F0s+yYArjaSeua+CUZbpHsQlKGsTnofhy0kh/tHWZHixykEYXd+PWuy02ws9LsltNMtkt7cHO1eSx9SepPvU1sy3EIdGVhjqDT3GRg1LKqVp1NJMb69Np9aOaXJJ56GjI9DSMjm9E8PpfWrSzy+WmSAAOSay9d0p7CVFIyvVW9a1fD2pmEmBziNj19KseK7i2kgiVHV3A6g8Yq3udinNVLPY5fwrftpXiq35P2a8PkTLnjJHyn654/GvUnGCQcZBrxqVTNqmnxpyz3UQXH+9nP5Zr1TxNevp1hPdRjcydBjINNq6ROKjeatuzRQnehPQd68U1C3fTvEep2lwPnW5aQE8ZVjkH8jXWeHPGF5f6nBb3cYKzEjAGCPpWn448MvrYivNPKpqkC7QGOFnTrtJ7EdjRKDg7MdB+wm4z0uZvhu+WOMwudq/Wm+KbiOWQKg4AwCO9cat9Lp0xg1CGWznQ4ZZVI/I9DTn1F76UQ2cct3MxwscKljn+X50tzq9hafMavgmMz+O7HYOIY5JnI7DGK9V4LEfjXN+BvD0mh2c0+obP7UvMGQKciFB0QH+fvXRFuPalLscOJmp1LrZHPfEO/l0/wAKXBt32y3Mi2qsDyobJb9Afzrz7SLIOIoogOcKBXefEa0e88JTvCA0lpKtxgd1HDfoa4jRLxY5IpVIO07hjmjodWG0pO250V34Xmjty6umQOR3/CuTv4ZtOmW4hbZdWreapzyCO35V3v8AaaSI8jPlm469BXFeIbhDHcugBLAhQOpJ4AoWj0LoSk3aR65Z3a32n2l6nC3ESyHHbI5qxER56gjrxnPSqGh2r2Gg6ZZyf6yGBVb2OMkVcIwep60O1zzJWTdjyCxU2k09rLw8MrowPrmuos9ceCAIFzitDxR4T/tO8OoaZMlvfsMSK4+SXHf2NYkXg7XWGJJrGEeoJbNFz0HUpVVeTKurar5m6WaQBVHU+ldB8PtOmt7S61W8jMct7hIUYYIiHQkds1Jo3gyzspo7jU5zqFyhyisMRL/wHv8AjXTuxYZbr2ouYVa0eXkgLyrAgnNMmiguHLXFvBM4HBkjBNScc+nSjFI5bhkbNgARBwFUYx9KQDBz69cUH889vWhhtUGQrGnZmYKM+lIQE4Bx09qIvnYLzzSR7JQTE8cgH9xg38qdEWWRMAA9OaYHl3ivU317WZotx/s+1cxRRg4DsDgsR35zist7SMrhY1I9NtV7RnjluI5BiVJ3Vw3UfMc12+g2dnPZN5qjcRjce1N7nrtqjFJbHM+H9WufDV6JYWd9Pc/v7c9Mf3lHY161CySW0MkUplR0DK56sD3OK81vtPXzSi/d3YJ9a7TwgPL0FIv4YXZAab2OTFKMkprc1mBbAGQfaoLy+srHJvb2C3I/hdwD+VYvjPXptJt0tNPA/tC4UnzDyIk/vY9fSuBtNL+0Ozy7p535aST5mY+pNKxFLD865pOyPUtP8QaXqMmyx1KCWQcBS20n6Zq3JvBPmEk+/NeP6hpSo2HTa45B6EfQ11vgPxBPdSNo2pyebcRrvt5Xzl0HVT6kdqLLoVUw3LHmg7o7JCY/u54HeuV1rwPaahcNdaTMdPuXOWUDdGx9cdq6maWGC3lnuZRFBChaR2/hArzrV/G2oXzMmjAWNn0WQjdK49eegpIihGo5Xpg/w/10uEa9sVi6mXDZH4YrqfDPhez8PCSWN2utQkGJLpxggf3VHYVwMGva/bSebFq9w7DqsuGU/ga7bwd4pGtl7G/jjg1ONdw2fdmX1A7H2p27HRXVbl1enkdGB8vPI9TUkBCzoT2NNHp6dRSNnjH60jhPDtWsZNF8UalZzArmdpoiejoxyCDWrBqKpAECqD9etekeItB0/wAQ2yR6jGwePPlTxnDp+PpXJN8NWDAJrbCM9N0ILCjzPThiqc4pTdmedeItNtdZnSL7GJ72Y7Igg+cn6jt9eKhkjPwp1aUaZqy3kt5aeVPEEwYnPIIIyGwfp1Ne3+GPC+neHhJPbq1zflCGuZzubHcL6CvlrxC0l3r2pTyy/N57A+wyele3gMwxKpTw7m3TatyvVfLt8jOGFw+MrqXLbl1vs3/wDa/4S+5uL0G7gkmP3jI7Z+b6ZqB9WvI2knifCORwT0rHtGjaRM8kDH1pZXJWUbj83ABqlFI9tUYR0SPQ/BPj+4sbqOG4lJicgcnIr36GT7RbxyqMiRQ2RyOa+PUs9tuJTKAxPAHUV9FfDHWZ9Z8CnYxE1rmPcepwK4sXSWkkeXmOGjFKpBHapLE7FY5UY+gYGn4P+TXk+hQ6vdeKBKkbgRN87tkDGa9P+2xf89F/KuOdPldlqebUp8ltTzS11FQu1mKyKMFX4YH3p95qUajLug9MmvUdR0nTNSOb+xhnbHLlcN+Y5qrY+HtEsZBLb6XbiTPDON5H0zSujo+tQ3tqcr4F0W4u9Si1q+jeK2gz9licYaVsYL47Adqu+PPFkOk25tfI84zddwwBXbPvIZ5CAo/iY4H61ia9oem+JbQW87wSMDndG6lv0qoNXTa0MfaxnUUqi0Od8Nvoll4euPEwim220byS7QXKKoyxVR1wMnjmt/wz4q0LxTZi48P6pa30QAJEMmWT/eU/Mp9iBV3TtHtNM0wafbQBYACrK4zuB65r4a8T+CdZ8LfE3XLHQxqEMOlE3wubLJlhtCy4kXDAsVDgHkdD0wcOyqN6mM5c0mz7vnSKddtxFFMo6eYgbH50QRxWylbWCKHPURoFrmPhtMlz4N0+4g8Qz+IoZV3C/mVFZuPu4UDGCOQ2WznJrpx655781k9BXdrC4BbJGaXAPGMfSkP3TjNKOQSOnqakQYHIKBlIKlSOCD1Feba74Mv9MuJJ9BjN3YOd3kA/vIfYeor0nI4OcA0cjlTz0zTua0q0qTujx1BqbtsTStQMh4x5RHNdR4U8I3Rv4tT8QIsQhbfb2YOTu7O/07Cu98x8feY/8Cphz1J5p3sbTxUpKyVhzsWbcevqRQB1xQOpFKBmkcg0AADnPvSHr16U4dBTJpEghlnnbZDEhkc+w5oAivLi3src3F/cR20I/ic4/CsB/G2g7yoku3UjG9YTt+tcRf3s/iHUDfXwJQ/6iHPyxL2GPX3q5b6ZLLGXihYqOuBVaHfHCxS996nouk6pp2rIzabdrMyjmM8MPwNXMdc15BcW8lvcLcWztBcxNlZE4ZT/AF+leleFNbXWtJN1cBUurbK3KjpkDOR7Gi19jGtQ5Pejqir4s8RroiJbWiLNqcy7lRuViX+839BXnd291qMzS6jczTysc/OSF/AelPiuJNU1G61GY7pLmUkZ7KDhR9K7e18MQ/YoZJ5AJXIY5GRt7j69KTutjpioYdK+5wqwyWhElpLJBKOQyMRivQPBXiFtage2vdq6lbKCSOBKv94e/rWZregR2tmbiFyUDYINYPh2RrTxjpTx/wDLSQwsPUMKa10YVFGtBtbo3PG3hq4kvX1fSIjM0mPtNun3iR/Gvr7iuVh1h7PdHJ5kJ7rIpBr2TG1vl4INMkjhuMGeCGUg8M6BiKVznp4nljyzVzyvSm1LXLpYtOt5GXPzzupVEHc5PWvT7C0jsbOO2iJKJwSf4j3NWC2Igq4VR0VQAPypvUYycjvRcyq1vabKyPNfGsp/4TK6iYnAijK554/wrQ8KRB74EkYUZ+pqX4laXIy2+tW0ZdoF8q5Cjny+zfga5vS9WNv+9gfORxjpTep2wXtKK5TrvG8MaQxSLgO3bviuH0yRrfxTpEseTILpUwO4PB/nVzUNTku/mmcs31qX4f6e2qeI11AjNlpxLb+zSkEBR9M5NJFwj7Ok+Y3virdtHb2Gmxk7LuRnmx/Eq9B+ZrnPDWnR6lqaQykiLGWxXSfFGzkn0uy1KNS32NyJQBk7Gxz+BrltB1H7BerOuGVvQ8EUyaH8D3dzs9T8N6fJbPHaxlGUHBz3rzt5n0nWLW6ibElrOMkdxnBH5V3eo+KYBZt9lX984xz0rhLe2l1nXbKwgUtJNKJJSP4UBySfQULQeH5rP2mx6VeeLdHtfGFt4curkw6pdwfabdHQqkq5I2qx4LcE4Fb2Bx/nFcn8UPDWieKPD80Wu3CWCWp8221HeI3s3HR1ckY6DIyM/kR87SfHHV7HxF4a0/Ub23vYNHvnS+v7RyY9QhKhFkx6hWc+hbB4pxhzbHmH1oec0nP4elNVw6q6MGRgCGByCPWuX8YeL4fDZjSSFpJH5yOwqYxcnZFRg5vljudXHjec4OQRmvlDxzpb6b4q1iFkIV5S68cYNfT2gapHq1hHeQgBHHFct4+8EJ4gt5riJgl3/D7/AFrow9T2UmpHXgqyoVfe9D5p08oSJWkO7jaOma1ruzUwecGVmK9V7VJrHhfWtPuXV7CcqGxvVCRWd5Woi3e3isLlucswQ16iknqmfQKcZaplXe3zBvlQDINfQvwJtprbwK8jxkedKSm7jcK8n8I+A9T1e+i/tXGm6bkGSW4O3I9BnvX0LpmqeHoEh0rTtUsx5QCou8Afn0zXHi6iceRHm5jWUo+zjqakYUEkALuHOO9V/sEXvV3yT5igYAPfrke1TeVH/eWvOTaPFuT5xxu5xWL4o1+PQbONlRZr644ghJ/Nm9hWyeSBnk15j4pm+2+NL9m+5bBbeMHtgZOKpGuHpqctdkZ919u1abzdVupbiQ/w7sIvsFHFMbSUQCSMFGB+VkOK6fw1Yrd3qrJ9wDcR6itjxQsIgjEcSIF+X5VobZ1utyy5EjnfDfiu60uaO11mWS6sJGCrNIcyQk8cnuv8q7s6ZZx6rLqKQRm9mhSBpwOXjUsyr9Mux/GvKNVRTE6noQf5V2a69Lpfw207UGw1/JCsNuG7seA34AZp/ErmWIoptOC3OU/sCH4dePDf6HqlvaeH9S3yahoZBZklx8skCjhcnGQcDHrwF6dfiDYeZhtNvVi/v5BP1xXF6VplxfXLN8893KcySvyzE+pre1DwtdWMW8skigZYxnpQ2upaw9KHuyep3Gj6rp+swvLptx5m378bDDr9RV/Gc5xj0NeNWF5Jo+tWl9AdpSRVkHTejHBBr2aUYkbHTr+FJpbo5sRS9lJW2YDryccUHgeh9BSDrnj2pVG0YFSYCAY6CmMvUg4FSfQ+1HY0BcQD160452nBwe2RScZ/zxSmmAgBxg9fWsbxmrv4Q1ZYgd3kHp6Z5/StnoMn8KGVGVkkUOjqVZT3B7UFRlyyTPItP2FUIPBwQa9O0uSI2cQhCiML81eb63pU/hm/MbgtpznNvP2A7IT6iprfVXSPEcpC+gPWmejVh7ZJxZqeKI4hfMYQAD1x61H8Odz6/q9r/DcWgJ+uSP61iahfrtaSaQAeua6/4daVNZ2l1ql4jRXF9gRxsMFIh0J9z1px01FU9yi0zhtLBs3ktpRtmt5GjZT2INdzaeIIzZRJMp8xOAaPF/hR9SuW1HSmSPUCMSxMcLMB0Oexrj2stZt38ubSr3eOPlQsD+IpXHeFdXvqdDrWuNeQrCgCx1S8E2baj4oW5IJttOBd27GQjCr9e/4U3TvC2tamwN0v9nWp+88n+s/4CtegaXp9ppNhHZWMeyFeST1du7E9zRcyqThTi4Q3Lmecjqe9L9Pxpo5wf5d6U4znipOAQ991JjNKOvPWlVSzBQM+1AxobgjGQRggjqK5bV/AGmXTNc2ssumSNy2wjZ/3yeBVTxT4wlhu5dO0HYZY/lmuyMhT/dT1PvXGXMNzdMz3dzdTs3JLyE/pVWtudlCjUXvJ2OvtvhzaSPmfWJ7uMdY4iq5+pHNdha28FjaR2tnAsNtGMLGowP8A9fvXixtZbSQS2k01vIpyrRuQQa9L8EeIH12ylgvsf2laY8wqMCRD0f8AoaT12KxNOoo8zldHQuVaN0kRXjddrKehHpXC6r4CbzjJoN2sMbc/ZpwSqn/ZPYe1d0eefbpSc0jmp1ZU3eJ5vb+BNbmfF1eWdrGD95Mu2PYV2fhzQbLw/bSR2W+SeXma4k+/J7ew9q1PTFFO5U686is9iG4gguoJLe6ijnhddrxyKGUj3B4IryTxt+z94R18yTaUkuhXjchrUboSfeI8fgpWvXLiUwwSSbQSqk4rzHUPGWow6gjSS7oS2AEHCj3rSlGUvhJp0pVHaJ0vhmDU/CHgPT7TXJor67sI/s6zQlsSxrwhII4O3aD15HWsJ5Lbx1qCW15bGF4+sinPFP8AE/i6VvDsc0UGY3O1jjNafw/jhvIY79IPLAXAbpk1oouEXJ7m8IOlDna1Oo0jTrfSdPisrRdsUfT396t8jPf0pw680gJxycmudu5zNtu7EwG+8ikehFYPizXbXw3BEltbQy6ld5MUZUBVA6u3tW+uSwxxk9TXlfjhpZvHl79oGPLjRYv9zH+NEe5th6aqTs9jMu1utUlaW/la4kY7iMYUfQdBVWfSkaPmMY69Oldx4ZtreSFnlABA6eopfEcMCtm3UKMZxjHNGrO9V7S5EhPhXrcsnnaBfM0ssMZlt5XOSV/un6VR8zWv+ep/75rN8JzfY/H+mSAE+YWibHoRXsH9kw/3V/OrUrHJieWnO6W4pwDkdjxXnPja1ax8S/a+fs2oKCrjtIOCM9q9EmjSRNrhtpHVTgis+80e1vrB7O+aWeBuRu+8h9QfWouYUaipyuzjdEv/ALBOHXp/EP51f1rV1vShChAP7tZd94U1rT2P2NRqVsD8pUhZB/vCqyaXr852Jo1wD0zIQoH409zs5acnzpoy9YcrC4UEu3yIo7k8AV03xDsZdP8AC/hqFgGjsysUxHRW2AA/mDWl4Y8JNY3ceo6zJHPeJ/qYY+Y4T/eJ7tXTX9pDf2ctnfx+bbzjbID/ADHoaOaysZzxEVONtUjznwxqK2V0pcAxng+1dhqOs2sdlJtdZC6njvyK4jUPCWuaXKRZxf2lZ5xHJEf3gHYMKht9F8Q3z+XDpk0J7yXJ2ItG5rOnTm+fmIbOxk1nX7OwhGPMkEspHRI1OST/ACr1+cq824joflPoOn8qxfC2gQ+H7SUGQXF9Pgz3BGAfRV/2RUPijxKmhutrbQi51KQbgjH5Yl7Fv8KHroc1aTrTUYdDoINzru8twASPmHocfr1p2CPY15TJrWv3D75NVnQk5CxYVR+Are8M+JNQS5MOryfarXqZSuHi9/cUWXRilhZxVzuVVmYhBkn24FUrnVdLtX2XGo20bjqBJnH5VxPivX5tVn+zadK8elp/y0UlTOfUn+7WCsEaDG0AevWiyW5UMK2rydj1y2nhvIvNs547iMfxRtux9cVJzn39q8lh8/Tp1udOmaCdeQV6N7EdxXpOjajFrejpdBSjPlJowfuOOoosnqjKtQdPXdGjyF6Yo44H4UikYGB9BTj79OlSYjZUjmheGeNJYWHzI4yDXN3XgjRZpS8S3FsT1WGX5fyOa6X8STQRwf50IuFSUPhZhaX4S0bTplmWB7idTlXuG37foOlbzMWYk5JpuQP8aUdyeoouKU5Td5O4dM8cU4O237xAHBwaaMnHfPanCJscLx+WaCRPmJOevrQBj8KcUZeGUgetNGNxwfamA7HPfPamHnj9AaD3OD6c0h3H2buKQgB9ME1m+KL6TTvDGp3kPE0cRCn0JOM/rWhg479fSq+qWCappN7YSEKLmMru64PY/nTWhcbKSvseSaPAirHHnPqfU9zXoNjpluloC0W4sMkntXm8Rm066ksb9DDeQnaytxn0I9Qa6O01yaOER7tyjgD0oZ6leEpaxJPFNrDBODCAAw5FUfh87p43VU+69tIJPoMEfrVHWdVDZkmfBPAHc/QV2Hw20KawgudW1VTBcXSYSN+DFCOct7n+goRNR+zotS6nVXVxb2tq1zezxwW6cM8jbR9B61zzeOvD6uQJrllH8awnH1rhNb1WfxLqTXc2RZIxFrCeip2Yj1PWnx6VcvCZUtpGjHUhaeiMoYSKX7x6nqenX1lqlsZtNuY7lF+8FPK/UdqsHOeeteMQ3F1od7Hf6exjmiILp0Ei91I717DZXcV/Y217b58q5QOo9M9RSa7GNeh7LVapkhG7IPIIII9a4/U/BNpLdSS3dzHb20hyodguPzq3438SvoSRWWnKrapcLv3NyIU/vEevpXm8kE19N519cS3UxPLStk/hVRk463NMPRm1zp2R6pb2OhzaWumQXVlMiDGwSqWNalnZx6fbR28SBI0GFXFeLS6Ui8hMHswGMV1/gHxFOl4uh6nK8iyDNpKxyQRzsP1ApN3HVw0lFyUrnoGcGkPHWk5BPc0E/rUnEGcc1wnxP02b7Rba5bIZIo08q4CjJUdm+ldznpj/ABpykjKsAVIwwI4IoTsaU6jpyUkeR6fqu2IGJwQffNP1DWAYy0j7VAOdxrtdV8EaHfymVIpLKU8lrZtoP4dKNN8D6Fp9wtw0Ut3Kv3ftL7lHvinc7frFF+91MH4baXLc6hJr9zCUt0XZabxy5PVx7e9d9vb1P51If4cKAFGFA4A9hRkUrnHVqOpLmZYzgjpjpikV1LsgOWA3EdwPWuR8TeMRp1y9jpUSXF7Gdss0nMUZ7gDua5p/FHiSXH+niPk/chUE/p0quXuXDC1Jq+x6ptGfl7H16UoYnvn8a4XQfHMn2lLXxBGgU4UXcY24PbePT3Fd2wwccH6H9aTi0Y1KcqbtJCY9DxSDA6HGaXg4x09ar3t1DY2dxeXbbbe3Qu574Hb8elIhK+hY+6hcsEQfxE4H51Wi1GwuJfKi1G2ll/uCYE15Bq2qX3iS5NxfsVg/5Y2w+5GvbI7n3qqbCIqAI14PHFVZI7o4LT3panuqJ+/VWHfPNeLLM95qt/dzktNLcPuJPQA4A/ACug8D+JZ9N1GDTtTmaWxlbZE7nLQt2GfQ1m+LNKn8Pa3cPIrHT7mUyQzfwqW6qfQ5oatsXh6bpTcJbvYfbReY3tWhrNk1j4YknDANOwUkHsTWJb3wAGCCPrWhY3UmtC60aPdJJKFaArkqCBk7j0HPrUpG0000+gujrF/ZpaVcpG4ArotLl0e4tZILyJUk5Kv3+lchveyZtPuFMdxA37xT6+v0qbdnGMc9fpTZE4c3UluFVJZUjOUB+XJre+HDNu1mMH92rRuBnuQf8K5e7u44IWdyFA/X2ru/BGly6bogku1aO8vJPPkTuoxhVP4c/WiJGIaVOz6m+pz60AEZy3f9PSjPOf60ue5oPOF47Hj3pD6nijPTmk4xnBpAIcD24pC2KCfTtSoN8gUdCe9AjC8VeIjo0cdvaqJNSnBZQ3SJf7x/oK4O6kvr1/MvL+5lkPXDlR+AFT+IZ2u/F2qSc/u5BCPYKP8A69bfhrSI9Qd2uHKQxjJA6k1Wq2PThGNGCk9zG07WNV0eQPb3Mk8Q5aCdtysPqeRXpGj6lb6xpyXtoSFb5XQ9Y27g1y/iDRIbOLzbc7ojwVYZ5qv8OJXh8RXdjyYbiHzSPRlI5/Wq+LRmVWMKkOeO6Or1/WbPQ7RZr0l3k4igj+/Ifp6e9cPd+M9buWJtVgsouwVd7fiTWXq13JrHiG+u5zkLI0MQ7IinAA+vX8a2tM8O3N5ZG6UKkPQEnlsUm7aIuFGnTinPcpQ+MPEFs4Lzw3K5zsljxn8R0rs/DPiK18QQv5afZ72HmW3Y5wP7w9RXE6jp7Wxw469Kz9CuW07xZpc8f8cwgYD+JW4IpXvoy6lCE4txVmeo6tpGn6zCE1O1SYqPlfo6/Q1zcvw6sI8OdWu4Ic52uV/LNafjXxEPDtskNuqy6nck+Sp6Io6ua8vuFn1CUzajPLdTk8tI2fyHQUl5mWHhVcbqVkeqaL4W0WwkFxYQx3dynSaWQSFT7DoK0ddSWTQtVWPPnNbSAeudprxhbJraRZrZpIJU5R4mKn/69eheAfFUuoTHS9XYPeKpaGYgDzlHVT74p+gq1CcffvzWOM8OCGT7MHA2YXivV9PuEYYjZFhReV4xivMfEmkT+GdQkZY5G0qRi0MqgsI8n7remPWoF19RBgXKAeoakbVaft0pRZZ8UvF9tumjx5eSc+ldr8PkZPBekLLn5lLD/dJ4rgdJ0q78V3IjtldNP3j7RdsMLt7qvqx6V61GkcEccEChIYlCIg/hA6UzPEyUYKn1PJfFxaTxzrBl+8roq57KF4xW94MsYb25kEiqzou5VPen/EfRJzcrr1jG0g2BLuNRlgB0cD+dctYalsAeGTg4OVNJm8X7SilE9E160sVtDhESXpha86hUt4o0ZbXPmfbEA9cA8n8s1LqGsfL5k8uADnLV0/wx0WaW+Ou6jE0QIMdnG4wxB6uR29BQSl7Cm3Jmn418Wpod39h0+FLjUmG9ix+SFT0J9SfSuSg8b+I4pS87Wlymc+W0e3j69qxXlkv9U1C8ueZpbh9x+hwB+QroU8NXr6eLvYNjLkL3x61TdtBxo0qcUprU7Hw1r9t4htmeBDBdRHE1ux5HuPUe9bGCRycV45aXcmia3aX8ZICuEmXsyE4Oa9lJUkNGdyMAyn2NS0cmIpKm/d2Y3HFKRzQQAMAD2pCRuwPrmpOYXimYHqfzpx4BOCfpT9p/vfqaAPG9HtxtDPlpH5dickk967OHw2z6clyGXcwztrjNOmeCY29wpjuISUkQ9mFdPba1IluYlkwh/KrPVrc9/dMTUrJQrI6gqRg16H4FmmvvCtm1wS8kRaEk/wB1Txn8K5Yz262s9/dDMUX8Pqew/EmsN7/Ub6wkRpZILd23eRCdq/j3NNbWZFSDrRS7HsQjZvu4b/dIOK5X4m+Z/wAITeFBx5sXmf7u7/HFed26TWrCSzurmCQcgpIf69a7Dw34l/tUPoHifbNDeKYo7jGCx/ut7+hoUU9jL6tKi1PdI5XS1jd0D42EjJ6cV6Pq82kTaK6RpCo2ARhRgg15rrOl3vhe9a2v0drMNiC6Ayrr2yR0PsaiOsxiP/XLjr1otodNSl7VqUWN1jCQOw4ZSCpHqDxXtW1brT4kvYlkSWFDJHIMgkqM5rzPwj4dutbvoL6+hkg0iFhIN4w1yw5AA/u+pr1JmLMSR16/0pPRWOTGTV1Fbo5tvBPh0yeZ/Z5UddqykKfwrbsrK1063MGn28VtEeojXr9T3qbBNKoI69vakcsqk5K0ncx9f8P2GubXug0VygwtxEcPj0PqK54+BJgx8vWiFz1aLnFdyfXHOehrmvE3i610WdrS3i+3aj1aMNhIv94+vsKErm1KpV+GBJovhLTtNuFuZWlvrpOVkuPuofVV9a6Ikk5bkmvNT471wPu+y6ft67drc/jXT+GfFtrrUi2c8P2LUT91CcpJj+6f6Gna+w6tKtbmnqdFjFKAM0pznHp3xR1x6dKk5g9aCe/el/zxTTx+PcmmA0jknH40LkfXrUGo31npsHnalcxW8bDjeeW+g6mseLxnoBn2i7lXPG9omC/ypqLKUJS1SOW8aWn9n+LJZcYgv1EqN2LgYYfyq7oOoi1b5ydp64rrr+x0/wASaQ0TSrPak7o5oWBMbeo9DXE3HhLXLJ8WqxX0P8LBtjY9we9HqdtOpGpDkm7NGtrmspcQCKEfL0yar/DmFpvEV7fDiC3i8o+7MQcfkKqWfhHXLxwLxobCA/eYtvfHsBxXd6VYWuk2EVnYoVhQkkscs7HqxPrVJ21JqThTg4Rd2zyrULWTR/EN7Y3O4bpWliY9HRmJGPzxXQ2PiB4LH7KCNnUH0Peuu1zSbHW7cQX8RJX/AFcqnDxn1BrjpfAV6jFbTV4XTsJoyGH5VNylWp1YpT0ZnapqJuBlu38qq+DbGTV/FNvcRx7rOwbzZpOgL/wqD3Pet+08AF3DatqjSx94rdduR7sa6+ztbewtI7SxhS3t4/uog/U+p96kdSvCMeWGp5h48uXu/Hd4smQLaNIYx7EZJ/OtbwlZ2s8xa4AYpyAelTfEbQ5JJhrlihcqgS6jUZOB0cD271zmkakIiHhkHI60bmsffopQOv8AE9tD5G6NFwDngVxNu7W3iHSp4SfMW6jCgd8nB/Qmte/1oNa7XcYxyTVjwNokt/qEevXwEGl2hLwGQ7fNbGN3+6PX1qkhR/d03zno8nEjrgFCSCp5BrPOj6SJzKul2ZkJ6+WKybrxv4fhkdUnnuTnLPDESue/PetfSNX0/WYmfTLlZSn34yNrr9QaHFnn8tSCvZpF0YWMKiqka9FUYA+gphUBmYDDHv60/sQO3pQdoVnkZY41BLsxwAKRAgYqTn8R61z2peD9Av5Wmk0/yZWOS0DbPxrM1Xxy/nGPQraKSJTj7RcA4f8A3R1x7mqtr461GGTOpWNvcQHqYPlYD2B607HTCjWj70dDe0zwdoOmyiWKxM86nKyXDb9vuAa6KOQmVXOMjgD0qpYXlrqljDe2MnmW7nIPdW9CPUVYxyAcY71JhOUpP33qeSX9t/ZvifULWThFmMq+hVuR+HNehWupWc2mBpJUBC/d71R8e6DLqltHqGnpuv7VdpjHWWP0+orz631AEFS5RhwyNwV9sVW53qKxEE76of4idJEunAAU5xXq2gMX0HTJH4ZrdCffivJYrWXXNQh0zT8u8h/euOREnck17LHGkEMUEX+rhQIv0ApMnFtKMY9R27BAPQ0Z7ZoIP4Vj+JvElj4dRBOrXN7KMx20f3iPVv7o96SVzijFydo7mx9en86Xc/v+dec/8LF1AS7hpFp5P93zTu/OrX/CyV/6AMv/AH+FVymrwtX+U6PxH4T0/XJvtTM9pf4wZ4v4/wDeHeucHgXVVbEeqWTL0DGNgfyzXog6enc4piryeOnFStBQxNSKsmcNrvh5NI8HXTz3b3Mkboz7V2qPmA6fjWPpbQyxlMrg8DFem3dvDd2c1rdJvgmjKSD2P9f8K8n1bR9R8M3GydHmsc/urtBkFfRvQ07nTh6ntE4t6mrd6dbrbs5cbh/nFcxqW5IfMT/WI6shH94MMVak1hJodu8v/uAmtnwx4XutXvYLzUoZLXS4nEiq/D3DA5AA7L3JoSs7nTzezjebPTJf3sCLcKrB41Low3Akjng1Qj0jS47kSxaZYrKv3XEK5BrQlJdi2cHuPSm4yecD6UPV3PHUmtmK0hbknNA+bt+dKB6dKUdDj1pCDvzRwfSjOT1GO3vRjkA/5NAirqd5/Z2lX97gF7aB5QP9oDj9a8c0yAyAySsXllJkkc9WY8k17JqlmNR0u9ssgG5heIH0JHH6149pkrw7oJ1Mc8LeXIjdVYcGn0PQwduWVtzopdCuBYpciImL1Fc5qMLRjzIWKTxnejLwVYdK6weIJjYi2JBQDArltYuljgkc/XHcmls9DopObdpHrmj3w1PSLG/GB9ohVyB696t//rrB0+a38KeDNMXVpPLaKEL5Y5d3PO1RXOXPjrVZ5D9gs7e1i7CQb3x71bWp5yoSm3yLQ9Czz1+lVdWvotL0y6v5+Y7dN23+8ew/OuN0/wAe3ULhdZs0khP3pbcYZffbWt8QJI73wFPdWUgmtneOUOvOV3DNCj1D2EozUZrc4KWW41O7a+1F/MuZOcE8IP7qjsBUiafJIh8uF2QdSF4FNsmBYEkV6Jpep2qacYE2o20jBH3qW56FWo6SXKjz3SdQufD18LuyyYSf38GflkXv+Poa9ctbmG7tLe6tWLQToHQn0I/nXlWu+Ws0mBgEZNdx8P8AengrTvNz8xdkH+yXOKe6OfFxUoqp1Oiz78fypjbsjBAGefp7U2TO3KpuORgZp5HBHqCKk4TLOoWM2ppAL2RJYiR5aybUY/7QHWtFsK2euRXml54Q1h9XJhA8tnLGXfjjOa9Kt0KQxxk7nVQCRzmrnGKtys1qQjFKzuIx96QHnjtUjQvj7pxUYXn6etZmYZK9DXO6j4O0W+maYwy20rHJNs+wE+pHSujI4H0pjdAD245oKjOUHeLsc9p3grQ7eUF7eW9cnj7S+4D8Olcv461uXV9Vl0m2YppVkRGyJwJXA5z/ALI6Yr0uAkPwOQpx+VeKaWSxkduXaVyxzzksapOyudmGbqSc5u9i3Bp7uhMULOFHJUdKrK01hcx32nSmK5hOVYDGfVT7V6b4ceKLRo1jVeQd/vXC6+EW5nKY2bifSlexvTrc8nFo9K0jUY9W0m01CNdonTLIv8L9GH51znxLunS1sNNjOBdkvOR1KL0H0zVv4bxOng2zLA/vZZZFH+yW4/lUHj3S5bnVNOuBLEgSJozvbGOc0ddDipxjGvbornIwxDbgDr27VYurRVt1yxDnBypwa0f7Gu4bU3PlrLAvV4zu21nXLg85yD0xSO5S5noaHw6umttevNMB/c3UZmVeyuvUj6ivQMZxXnnw/tzc+KJ71f8AUWcJTce7t2r0PoBkD8KbOLFW9poAOGJDEY7Vnajo+k6jJ51/p9vPL3cr8x/LrWgT8wBP4UKD0JJ5Jyf5UjCLcdUV7GxtdOj8nT7WC2iblhGuCan9iKd3IzzSZ59qQNtu7HwAeYAxOME8968NuLmTVdYv9RuDmSaZsZ7KDgAfhXuUBAkBIyM14rqVidI8R3+nSAqElMkRI+8jHINUtjswNuaXc0LTQ7q6tWmii3IBmq39l3P/ADzaus8Oa2sFmYGAVau/2jB6foKEjV1qik1Yn8F+JJNaV7DUgv8AaEK7g6fKJl9cdj61038Rzn2FeU+HZGt/GekNH/HIY2x3UqcivVgCJJCzlwTlQQBtHoMdfxpy6M48TTVOfu7McBz3oJ+VlP3SMMpGQfwoAx1ye1L6kCoOchgt4LY5t7a2h7/u4lWpXJLElix69aT0znFQ39ytlZ3V3IAwtomlx64HApj1kzL8ReIrHQh5c+Z75wGS1jPzY9WPRRXJyeO9Ydi0FnZQx9gVZj+ea5uz8y8le9vHaS5uD5rsfU9B9K67TfCk11aiZ5lhL/cUrkkepqr2PQ9jSpL39WWtI8dxySrDrlqLbcQBcQnKZ/2h1A967TaOMMCG5DDoR6ivIdSsHgllguUwynawPf8A+tXafDe+ku9CntZ3LyWMvlqSf4COB/OnpJGOIoRjHnhsdSgCoAAAoGABwB9KMHDbjuycjjGB6UDrTu/86g4xpz26+tcz4q8JW+tzfbLWYWeo4w0gXKSD/aHr710pyH2gHpn2xTs5yccUFwnKm+aLPLJPB/iSOTy0itJVPRxOAv1wea6Lwz4HSzvIb3WZku7tG3RQIP3UZ9Tn7x/lXYd/1p8OBKrds800bTxdSStseTeKL99b8T3MrNm2tGMEA7ADq31JrQ0XQrjUg32fYiL1dzgVgLC9nql9azDEsU7gg+5yDXY+HNaSygaKQblznHvT3Z2VLwglTMHVdOlsZnhuFG5e4rT+HF3/AKRqGg3SCSynjaZEbt2YfjUPiLUf7QuTITwOAPak+HVu03iq7ulB8m1tyjN/tMeBn6U46Cm26LcjJ1zRL3w3dOGjebTc5huEBbav91vQiqcWtQopInUfQ17QTxtwCCMEHvVQWFksvmLZWiyE/e8petK5isYmvfWp5bo+j3/ie5CxpJBp5P766kUj5e6rnqTXrUMUcUUUFsgSCNBHGg7KBgCnDc5AyMDj0Arz3xJ4wuLmeSz0FjBbIxR7offkI67fQe/enuQ3PEyslZI9GELn+E/nTCpU4OQR614xtvJDva8u2c87jKx/rWzpHi7U9IZUvne/sQcOr8yKPVT3+hpWT2Y5YOaWjuemgZLfMFGMsSeAO9efeIfGNzdTNa+H28i0QlWusfPKf9n0Hv3re8bamkfgqW50+UPHebIo5FPO1+v6AiuN8P6b9ru7e1jO3cMZPYUbDw9KNnUmVUu9UjYOmp3wf1MpP6V1fhTxZNNdx6drhVpJTthuVGNx/ut/jWhH4W0yUGBZ5fOHR93euD1q3aFZ0Y4kiJww7EdKOZvc2/d17xSPXXUqxBB4puOMiotNuDd6VY3LHJlgVmb1OKsdDUs856OwkfyOG9PWvKPFOlvoGuzsVP8AZ905lhkH3VJ6ofTmvViOeM0y4ihuYHguYo5oG4aNxlTQa0KvsnfoeX2mqvBAUST5SPWqdlZXXifUfsWn5MWf9Iuf4Il789z7V3b+CPDxl3m0kUZz5azMFPtjNb9lBBp1k8VlBHBDGjMI41wM4/U0XOmWKhHWC1ON8VeIG01o/D/hwiJbWJYpbgcmMY4Rf9rHJPvXKiz+0Ltnkkmk67pHLH9aj0vM0RuJG3SzEyOx6liSa6LS4rY2MjScSgnnvjtTu9kbqKpR03Mazn1HQiW0+ZkU/ehb5o3+orVXS7vxHEt1oqR26SHZN5h4ibvgd6qO5kXrkfTmtDwBfSW3iKfTWb9xdRmQr0Cuvcfgad7iqXUXOK1Oy0PS7fRNKjsLY7gpLPIcZkc9TV7OPbnB+tCkMMggg9x6UvoRzz1zUnmNuTuxhyWwenXNKoJOMZ4yPWmzzQ21tNdXb7LeFSzk9sV53qPjDVtRkP8AZ7f2daZ+UKAZGHqT2+lFjSnSlU+E9Gwfujg9aoaprWmaQQupXqQykZ8oAs/5CuItvFWtWFpKXuY7iSQiONpUBZff3xWFDaPdTySys0lzId7u55c07Jbm8MI7++9D1LTNf0jU32WOoRNKeBG/yN+APWqvjDw1H4hgjZZBa6lb58mYjIIPVW9v5V5rd2KuCJF2svQjgg+xrvPAWuyalbTadftuvrQBlkPWVPU+4o06DqUHR/eU3scPc2WtaXKYL3TrnI43wqZEb6EU3zNT/wCgXff9+mr2NXcZwSB9aPNb++3/AH1RcPrj6xOI+H2jS3GoLrl4my2iUi1VxhpGPWTHoBwK78qzA9h1LHpUOo3kVhazXl4VS1t49zY6j0UD3ryfVNW1DxDcNLdyPDbH/V2yMQiL2zjqfrVPUzUZ4mTlsj1xJYZHxHcQSP8A3RIKlZSvUEV4l/ZyKMom09dynkV0nhvxTc6VMlrqkj3GnOQu9zl4c989xSST2HPCNK8Xc9HwPeq2o2wvdNvbUfenhZBnuccfrVsgHaVYFSPlIPBHY0hzweh9qg5E7O54ppMm2LyZhsliPlup6qQeld/pfiS3WBBdKxdAApXoab4r8Irqtyb/AEyVLa/P+tVh8kvufQ+9cufDniRG2f2ajHoWWdcVdz0pOnXV27D9fvxd3s1xjAc+vb3rf+F1s8elajeuD5d7OPLLdWVRgn6c8VS0zwPdXDrJ4gnSK3B5toG3NJ7M3YfSu7iSOGNIoUWOGMBURRhUA7UXsZV6sVD2cdSTgEAnnHWsTxF4p0zQm8m4MlxeEZ+zwcso/wBo9vxqz4i1M6NoN9qKgGSGPEYP98nC8fU5rx20iknkM07mWWVi8zvyzk0aLVkYbDqreUtjtv8AhY7+Z82i/u/+u3zYrpvD3ifTNecw2zPBeAZNtMMMcf3T3/CvN1s/lztwB7Vn3sUsOyeAmK4ibfGyNyrD3oUk9GjplhKclaOjPcjjqetB/Oqeh3/9q6HYX5GDcRBmH+0OD+tW0JIOV2nNJq2h5jVnZnKeM/DEuqSrqWllV1FF2yRtwJ1HTns1cNPJd2Hy3tjd27ZCndGcEk4Az7nAr2Ue30pHYsArDcuQcEAgY5BoudNPFOC5Wro8qsdE1vVjtt7JrSHo090NoX6DqTXomg6Tb6FpiWVoS+CXllf70rnqxrSLE43Enjuc0nXrjNFyKteVTTZCYyMmkZc5yB1zTj35/GgYbPPI6UjAyfFc8lr4X1eeE4kWBgpHbPBNeWaXCqogXoFwB7V6/qNouo6ZeWUh2i4iaPJ7Ejg146nm6deNY36GK7h+VlbjOOhHqD1qulj0cG1ytdTtbHRFuLPzQRnGcCuc1S3WJnXuM81etdZlgtnjV8gnIFZrm61i9Wx0tTLcOcFh92Md2Y9hSsawU025bGnY20l78J7kLHvNndPJF7or5OPzNUdEvvJlhuIn6YwR6V6bpGnw6TpltYW43QwpsJI4kJ+8T9TmuE8ReEbvT7mS50OM3Ni+WMCn54j6D1FNsypVozcovqzUl8QQ/ZZViiZJpEKCRGwyZ7g9j3rxGXxhqlneXVprCpdursjyfcYn144Pr0rv4k1CV1ii029eXpgxEfqa4/4reE9Q0hbTV71Il+1ExSJGd3lsB8uT3JAP/fNcmKcox54PY+n4ap4SeIeExMU1Pa+912e6uv0PVPBvxC8OajptlZrei0uY4liMNz+7yQOzfdPPvmu4DDaCCCD0x6V8m+GbXS4tasx4rjvIdOnUOHj+XIJ4Y8ZK8EHHNfUuiWGn6dpMEGjJGlhtDRCNiwIPcHnOc9aWHrSqJ8xx8T5NhssqR9g5e93ScflLuu1vmXmHHbilIJFNVdvQAZ6+9P7fMa6T5QidAylWUEHqDT4gBIA3CEbT7jGKC3HI/Ok4zkCgDyaS0bStTutOlGGhkPl5/ijJypH4H9KmDhQFzndxiu68S6DBrsEbiTyL+HiKcDII/usO4rhr/R9bsG2z6e8wzxJbneD/AFFM9OnVjUWr1JzpF9JbiYyRQRsfk38bvxq74N0mWPxY89wdy2kLDI6Et/8Aqptpbanq1tDZajp9xHBE2cnj6V2Wk2QsLZlwRI5BYk5PA4qmkloZVa0opxfUtgcYXA9h0FLn35FIy7lK5ZQ3dTz+FLnHPSpOE5H4n3LLpmnWGcLcymST3Ve35muTiTIHQGun+KUDCDSb1cmOKRonPpu6VzFu3QjrTfQ9PDfwlYn1WzePR7G86wiZo2PoSOD+lJFKFSMKvIxhs10NvPZ3mhXOlXhEayjdFJj7jjoa4/z3tWWK8Xy3Bwd3Q+4PpQ0aU25XT6GnqbI90xTnKj8/pS+DWZPHNoseP3kTiT/drGudTt1Y/vVZuwU5JNdl8P8ASX09LzxBrK/ZyYiIo34ZY+7Eds0rahVahTdztVUuPlGR60mE/wCekH/fYry/XvEOp+IJHWzM1rpgHyxRnDSD1Y9fwrn/AOyx/wA8pf8Avo1Vkt2csMHJq8nY9M+KMjLolhbA4We6G/3AGcVzOm2wfaAAK3PFF23iH4f2WsxxkS20oklQc4x8rfrWFp15HEEkYnyyM5xkAe9Nq2jNaKapWW+p0lx4daO280n5gM4rlb+3GGVhg45z6V2UniHzLbYVByuN2a5W+kUknP3jz3zUWsOg5/aOy+HuoPfaE8MxLTWcvlEnk7MfL/Wujx9K474XREWGqXOCIpZ1RCO+0cn9a7IkHJyPSqlucNdJVGkMOOW7e4pO+c49acSTnI74pepxUmJFEm2NFyTtGCWO4n6nvUgBxxSkdOevU0vcjOP60Ac747sZtR8I6jDApaZAs6qOrbTkj8s15jpE6PGjxng8ivbwSrZ4yP8AOK4bxF4DM95LeaBPHbSSHdJbSAhC3qp7Z9KZ3YWvGKcJaGZHfIttsUA5HesDV7hI4JJMHjge57ACtX/hEvFBYr9itwP7xnXFdH4c8EpZ3cV9rU6Xl1Ed0UEY/dRt6n+8RQkdDq06et7m94UsX0zwzplnMCJo4d0g9C3OP1rU5xwOe1DZYk5GSc0uMcdT/Ohu7ueVJ8zuwAIwTjdjnHSjA6elLjGc/p2oIOKQho6jmlUZJ/PJ6AUc46fjXN/ES9ey8MvHA5SW8kWAMD0U/e/SmlcqEXOSiupl6x47C3D2+gwRzhCVa5lPy5/2R3HvWUnjTX423yfZZk6lGi2j8xWfpViJnSGNQM4AA9K2tT8PS2duJGKt6gdqrmtsej7OjD3WjpvDPiK216JkCfZr5FzJbk5yPVT3FXNW0jTtYiCanaRz7ejdHX6Ec15OZJ9Ovor61JSe3fcuO47j6GvZLa4jvLSC7h4iuI1lX2yM0PXVHNXp+xkpQejOYHgPQhJnbeFM8oZjg10On2Nrptt5On28dvEeoQcn6nvUtxNDa20tzdyrDbxDc8jngCuKufiApnP9maW00A4Ekz7N/uF7UKNyF7WtpqztznHp6cfpSjIIxkenNcro3jeyvJ0t9Rtzp8rnakhbdGx9M9vxrq3BBwelJxsZzhKDtJWAuefmwawvF+hR+JfDl3pk7hGmXKOR9xwcqfzH5ZrcAz70lS4pqzKo1p0KkatN2lFpr1Ry3ibwRpWueHLfS5oxEbWIR2s6j5ocAAfUcDI7/XBry/wt4l1T4b60fD/iaNn0wvlJBlvLB/jjPdT3HUc98g+8MAeScrjmsnxF4e0zxHax2+rWyzxxuHU5IKkdQCOcHoawqUbvnhoz28uzmNOEsJjk50Za26xfePn/AF3vowXEdxBHNbypJDKodHQ5UqRwQakYgjINRwwJBEkUMaxxIoRUUYUAdAB2p4z+NbWPCla/u7DSOevvTl4PPXsDQMnrigdcdf6UEjMnpzjNOUtnr9KaR0JBFPA7nrQA/cxHU1GRzk/rThkjofpSHBIB+tMQiKWcqoOQAay77xFollOYbjUo/OU4YIC2D74rL+IGqz2sFrpdnKY5roF5ZFOCsY7D0Jrio7aGGMIAo79OTVWS3Oujh+ePNJ2PTGOl+KNKubGC8injlXB2H5kPY49q8puobzRL5rHVo/KmX7j/AMEq+qmleBoJ1ntJHgnTlZYzhl/xru/DurW3i6yk03X7SCe+txu+YYEq/wB5fQ+op6W0N1F4e7WsfxRxEl/GkRZ3UKPU11vw80154LnUtSgBhm+S3imXPy/3sHpWxa+EtAtJRLFpqtIOR5jFgPwrcJJK9MAYwBxUmdXExlHlgUrbS9MtpfOttPtYpT/GsYyKzPiFJIng+7KEne6I59ATW8cYA+tQX9vFf6dcWVw+1LhSmcd+2PeknZ3OeM/eUpa2Ob8LWdv/AGK0ioC4XPrzVXd/vf8AfNYtvqF/4Vu5NOvuDj5D/DIvqDUn/CSp/wA8Y/8AvurSOx05OTktUztfAdg1p4Pto7yI5ut00kb/AN1+gI+mOK5HW/C2oaNes+jxS3enOC6og+eH2z39q9PlLsTtfbnoAo6elRqjI+RI5QdQ75I9CDSerucsMRKMnLv0PGn1N0fZJDcJJn7jRtkfhitTSdD1XXpQGhlsrHP7y5nXaSPRAeSfrXq5OWyVQN67cmkJLEFuSvP0ouayxmnuxsyCxs7fTrG3tLKMx2sK7VA6+5Puam79T+NIzKiPIzBIlGWdiAFHc5rktQ8e2EU7RabayX23rKDsTPt60WctTmjCdR6K51hzk5+71AHrSqe/4VxcHjzobnSGCdzE+SPwrqNK1Ky1aFp9On8wLw6HhkPuKHFhOlOHxIu9x1pefwpFyBz0FPzgnnn2pGQ3kH2Pagrkd8E08HjNIcg8dO1ADGwckdaULngfTApWPPTv3rm/HOszaXp0FvYtsvL0lRJ/zzQdSPfnAppXLhBzkoos634l0vR5DDcSvPdA4NvbgMw+vYVjnx7Hv+XSJinr5oz+VcvpelmVwsSs7sc5JyWPqTXSP4XlSFmZl3gdBTul0Oz2NGGkndm5ofifTdXnFvGZLW6P3Yp8Df8AQ9623DKCAMnsGPFeP39ptypyjqcqw6qfWvSfCOpyat4ctrmY5uEJhlY92Xv+VNpNXRlXoKC5o7GsAOoJPFcn8TYC/h23uR0tblXf/dPGa6zOOnTpUN7aw3tnPaXK7oJ0KOPr3qUY0p8k1I820KZY7mJ852nr1rrdRuYvsUnO4sO54FcDd2t14evTZaiGCg/uZ8fLKvY59asPqBaLaX6ds0z0Z0udqSKupY2P24P416N4KJbwdo/mDnyjjPpuOP0rzSC3n17Ul06wy0kh/eSD7sKd2Jr2GCGO1toLW2GIII1iT6KMUdDLGSSio9Tz74l6i1zq0GkRFjBbKJZlzgM56Z9cCqOhaWL6UoSQqjJPel8coYvHF7vPySxROpxzjbg1peFdQt7USCc4Vv4sUM1V4UVyFDxDoaW8bL1Qrgg11ngHUX1Dw4qXDl7iyc27Me4/hP5Vz3iPUobnKW/3f7xrU+F8BXQ7266Jd3R2D1CjGaa2aMq15Uby3OvxnGe1Hv2HFBA9ePY/1oyDx2qDgGgYHCge1NwM9OcdakxTW3EHadreuM/pSAjuI/NiKbim7GSvX6U4nOTwAe1LgYwQM0v+7QMTtjvikxwfT6YpTj3J7U2Vo4oDNcypFAgyXdsAUAIfu4HUD60IfmrnrrxlpSsUtluZyON6phTUtl4q0iecQyzPbO3CmZcKT9arldzT2U7XszfB4OOgpT9KCpU56jqpHeg+h79KRkcF8Romj1+xuOqTW5jGfVTkiszTfJa+ha7XMS8lfX2rvfE2kjW9Ha2VlS5jPmW7n+Fx2Psa86sIbo3b281tJHdRnDoeMH/CnuehQmpU7dUb3iWys22TWSBFI+YDp+Vc7oUklr4u0h4eGklER91bgiurn0mddKSUvGS3/LMcEVjeGdKnvvFlvKY2S3sW853Pdh0Ao2KhNcjTdz0dgA7qMjBoUAEcdaU8sT1ye1Gdoyeg5wKlnnDMHuMe1RscduDUud0YZWBB5BB4x7UxlwDz1pDKd9ZWepQmDULWK4iByBIPu/Q9RWR/whnhz/oGn/v+/wDjXQquDnvSZ/zii5aqSjpFiprWkSSiNNVtC+eAJBzWhj5QykMh53L0IrxVrNMYKLkDGBWt4U16bQr+OCWRn0yU7ZI258sn+JfT6Vsop6I3ng7K8Hc9TA2nGc496Cchv5U+RdpPTBqIg5yexrI4jz74j6lLPqUWiwuVtooxLcAH77H7qn2GM1jafpz3DLFEmXPQAVc8dQNbeM5JW5juYVKk+oyCPyrU8KXUFtcF5cD5cA96rdHqp+zpJxMi906eywLiMpu6AmqtreyaLqcGoQHGxgsgH8aE8g/0roPFeqR3syLHxHGMA965uztZNa1e302AE73DSkDiOMEFmPpxwPrTjdMqL5oXmexPgkFeVPPPvSjtn17VXiu0mvJbZYZV8pAd7r8pHbHvVkDr+nFJ7nkPQRRgDB4xxinEHvnNGMHpS47dc0hDSB+NcJ8SonTUNIuT/qtrw+wbOf5V3pGODWdr2kwa1pUtlOSgJDJIBko46EU1obUJqE02cj4WnhguR5pIB711Mt9ZxI7NcAsvGByQfSvPL6x1TRJNl9bM8WcLcQjcrD146VU/tMSNhFlkOeioST+lP0OyVD2j5ky7qsyyTyOOASWOOwrsPh3btD4XSRxxczPMoP8Ad6D+Vc1o3hjUNbmD6hFJZad1bdxJKP7oH8I9zXpMUMcMUcUMaxxRqERFGAoHansjPE1Eo+zQhHHU59aQDPHH4U9umQMEd65/xvq8mj6Hm1YLe3T+TE393+834CkldnJCLm1FEniDVtBtUaz1qaGbd1g272Hvx0rl7K18BahOix+ZA78hJXdFPtk8frXO2lgvLHLO3JY8lj6k+tTzachGGTIx0p3iuh6UaCgrKTPU7DTbPTLbyNPtoraE84jH3vqepqZ/72TgAkqO4/z/ADrgPBmuTaXfw6XeymSwnbZEznJic9AD6GvRGBVjkjA4HalJdUcFaEoStLU5TxzoDazYx3Voyrf2inZnpIndT/SvNftbW5C3MckMnoymvctjc+WMjrj0qLyY0lc7I9rHOCBgUrm9HFezjytXPINJ02/8R3K29nFJHbZ/fXLqQqL3x6t6CvXLK2hsrKC0tIylvAgSNfYd/wAasbvlALKAOw6YrP1/VYdD0t72VfMcnZFFn/WOeg+lNa6Izq1pV2opF1gI4g0hSGNe7EKKZDJDOSIJ4ZfZHBryi+mu9Wm+0apO0zk5CZwieyiofsiROHh/dyDlWQ7SD9RR7pqsG7ay1PYGBBOc0hznHvXKeCfEU9/O+l6mwe5RN8Ex4MgHVT7iusGCcAjNS1Y5pwdOXLIac7fxxSE4xx+FUb7WdIsXMd7qNvG46qDuI+uKlsb6x1DJsb2C4I/hVvmx9KOV72FZ2vYtLjBaTCoo3MT2A5ry/XdXl8RXzSMSNOjbbbw54I/vn1Ndz4ume18JatJGxDiHbx1AJAP9a8807bHFGFHCqBTWiOvCwWs2SQwFiFAyeuBRdWeUZZI/lPUEV3Ph6C1TS45vKXzWyX3nJFZPiaS3kkDRbQcc4FKxrGvedrB8PNTlMtxo125cRr5tszHJC91/Cu05615p4Q58cWgTosErPjsMf416SCO5P5VT1OXFRSnp1HjaAzudqKNzMTgAetefa/4pGqThNIQwqvy/a2X5nHsPT3ra+I928PhuO2iYhr2dYif9jqw/KuJghAQBVGOBgelGkUaYaimueQ0tqMLGT+0p9w7ls5/DpXZeEPE0F7Kml3UK296QWR14SfH8j7Vyzw7TtYHjtis2/EkEkE9ru+0RSK6bRzkGi99GdM6UaiseyYA4yeeKcODgUrBm2yFG+dQxwO9Jnkc/jipPLGkYYlBgdce9NOFx608cZI5x+tIw4x6+gpWAiY8kYox/tindCQV47UZP92SkO5k+I9I0+10ORxGkDxcrL3PrmvNNSCm2Zt3ylchh3FbmoaxPdBVmlLYHGTxVHSNNk8Q6ullGMQD57iQdET6+p6CtlHU9OipU4tzZ6vppeTSNOaVm3tbxlvc7atYzjnpSnbuAUAAcADsO1ARuPkPPpUvV3R5Lepm67o9rrmnm1vFPBzHKv3o27EVwr+D/ABBbybbeS2uoxwsm/YfxBr00qeAQeKMDIOAB2pLQ2p4idNWWx5vb+CtZupB9vvLe0hz8wQ+Y5Ht2rs9D0Sy0S1aCxQ5fHmSu2XkPuf6VemkitonmuJEigjXc0jngVyreO7MTN5Gn3MluOkmQCw9QtUk2W51a6slodb1IBJxQq8c7hg561V0jU7PV7czWEhOw4dHGGQ+4q6Oec5HbFJqz1OZpp2YAAHgnHbJp2OOM/nQuTnIxzxnvQTjJPA96QgOBSY5zj3FOIz0HtxWBr/iW30ydrW2j+1X4HK5wseem4/0qkrlRi5u0Texnt9RimiNVO5I41PchQDXnsviPXZX3faoYv9lI+B+ZrT0fxfKtwsGtxxhWOEuY1IVSf7w7D3pqKexrLD1Iq515QE5bBPqTSFVHYY6VKVA9CD0NUdaupLTSLye2QSzRISiep7UktTBJt2RZAAxg/jXFfFGI/ZdIuMfJFOyMfTcOK2vB2pXGq6Ubi7iMbhtuMcHir2u6bHrWj3FjK20SDKP3Vh0NNx5XZm1N+yqLm6Hn2lJGZU3rxkZz9a7bWLOzk0p3WONSi5Ur3rzqGWWwu3s9QUw3kRwwPAb3X1FaU2pO8YUyNtAwFzxj/GlY7alOUpJpmLrYEcDup2lcMCOxHevUNc1uLSNHgvrlPMnmRVjgHV3Iz+AHevOtLsm8Q63DYwqTbxsJLmTsiA5xn1PTFbPxEmM/ie2gP+qgtgyr6Ficn8gKpKy1CrFVJxgzMu/EGu37l3vWt1z8scA2gfj3qfTfFGs6cVF04v7YfeSQfPj2ap9D0z7fcCIsAMZLH0q7rOgLaQF4X3xgd+1LmY26V+RpHW6XfW2qWUd5ZPuibgg9UPcEdjXF/EuUtrGlWx5iSFpsdtxOM034eztb+JbmyDHy7m3MmPRlI5+uDWl8SNLkuLO11O2QySWeVlVRyYz1OPanZGEIKlXSexz+k2y3d1FC7bQTya6LW/D9ra2vmRZXb1J71yFjdj5HifnqGFaN3q9xcQbZZCyAdzxUWOicZuSs9DMgf7N4h0qeFf3gukAA7gnBH5V13xG1uXT1i0rT3MdzdAvLKOqRZxx7k8fTNYngrTm1bXk1B1P2CxbcrkcSS9gPYdc0zx4jHxvIXBw1tGV+nIP65prQJKM6qT6Iw7ewQR8Lg7sk9SfrSSWZjkEsDNFMpyjocMDXVeGrSG5uVSc4Qjuat+KNLgsyDDnaRyvWo13Lddc3Ix3hjWD4n0q+0TVio1DySokHAlXs31BxmuHtxNY3UljfKUuoG2Mp7+jD1Bq5pszWPijSriMEMZhG3urcEV6P4h8PafreFvkZZY+I54+HUeme49qbZk5RoSt9l/gcNBfvHEAshC+xqlf6gsUReaQKB09/wrdf4fzbsRaywjzj5oecU+70nQ/B0cV5f+bqmpyH/R4pMYJHfHQAepprXYpVKV/d1Zf+Hei3FpZz6peRFLu9A8uNuscQ5Gfc/wCFdcY32/dP868qvde13V5S8l5JbIfuxW/yhfqepqBLvWLVg0Gp3ilTkbn3D9aqy7mNTDzqS5pNI6r4npnRNPuRytvdANjsG4zXKW0mGQjkqc/Wt/RPEU+v3Z0PxClklvcRMnmgMHmfsB2Ujryee1ZWpeFdZ0aTEETahag4SSL7+P8AaX1+lKSsa0fcXs56M1v3GphQMRug+cj0HeuevNUMknlaXEsUG7HmkZd/f2q7pun6zdWt8ItPniDQkBpBsP05qroFpEzRm5kVDjAX0PvSXcuKUb3ew2a/1hZw0OqXiMvA+fIGPau08G+In1mOW01AKup243MV4Eyf3gPX1rn9U0W6sCXdA8LdHXoazNJnaz8WaRMhI3TeU2O4bqKd76MidOFSGiPVsdT6c0jDt2NSuNjsOeD0/Gm7SGJySD0GOlQebcj2569R3pu1vf8AOpipyMfoKPyoA4+1+HsQkJvNVnmjB5SJAh+hNddpenWulWn2XT7ZYIc9urn1J6k/Wr2MZwPfiopXEMEkrDCxoX/IZrQudadXSTOU8XeK20yY2Olokl6BmWVuVhz2x3b+Vce+o6vc5kl1O8Zuo2SlQPwFVNPDXebmUl5ZiZHY9yTmuq0bQ5b5WYYULxnsabdtjvUKdGOqKujeLtQ06RV1NmvLP+IsMyJ7g9/pXo0TxTwRT27h4ZFDK4PUHpXm+q6c1rI0bDkdMCt74bXDNp99Yu2RbTZjHorDOPzzT+NGGIpxcfaQM74j3TT3lnpSkiJV+0TAHhj0UH+dYkFsSoIXHvWn4tw3jW6B4xDEOe9b2hWCTQEn6c0maqapU0cnazXOjXyX1ocunEiE8SL6H+hr0+xuUvLG3u4sbZlDjBzj2zXF+ILFIJNqcjGfpWn8OZS2jXNselvOQvsDzj+dNe8vQxxCU4e0R046n0HvRIQiMx6DnAGacBliBycZx6U/bnpjNTZnEY3ifUzpGjT3MY/ftiKHI/jbgfl1rzq2VYoyxJdidzknJZj1JrsfiSrDSbFsMVW7XdgdMqwGfxNctZSC1u4bgqJPLYMUPQj0p26HoYdWp3IvtUWdpyG9CMUy4CTIy7cqeCa7xdT0C+Hm3EUSydxInNZd++lTzCO0QLuIAPQUcjRUa2uzNLwZemXwlBPeyqn2cMjyM3ACnqSfasu98dQ+Zs0uxa5izzNKdit9B1qjr2BaJpsfFsCJHA6O3v7VTsdN8x1VW6/KBVNrciNKDvORoDxrqMcgA021MPXarEH866Tw/wCIbHW9yW+6G7Ubngk4P1HrXL6noc9ihLEEDAIz2rCmeTT7qG+tn2zQMGVh3HcH2pKSk7Mp0KdSPubnp+r6NYavGE1G2SXb91+jL9D1rCXwHpAlJZ7x4uuwzHBHp611g/eIHUnDgNg9sgU7bjNTaxxRrTgrJlWwsrTT7Vbewt47eAfwoMZ9z/jXJfEfT3D2mrRqSkS+TcYHRc5Vvzz+ddttDKeDz+dOdBKjI6BkYbWUjIIoQ6dVwnzHlmiag1ncpcQkEjtngitvWteF5beXGgQY+YDv7Uan4EdZ5JNGuxCrHcYJhlVPse30qvaeB9QuHH9p38UUP8S2wJZvbJ6U/I7HKjJ87ZV+H0DXfiW5v0z9ntITCW7M7YOB64A/WvRcfxcdMH/Cs2STS/C2jxq222s4xhEHLO38ya5e48e3LSYstNRYs/KZn+Y/gKrlbMZqeIlzQWho6l4K0y9naa386xkbk+QcIx9StQ2ngLTUkDX1xdXajokjbVP1Ap+k+OLa5mEOq2/2N3O1ZFO5Cfc9q65h0PY/kahxsKVStT92TIIIIreBILeJIoFGFRAAAK5jx9os19bQajYp5l3Zgh0HWSLuB7jrXR6jeWunWrXF/OkMA7seT9PWuYk8f6ekmLeyvJkH8eAv5A0KLJoqpzc8Vc5PTb9AqvBIMexwR+FW7vUJJwfMYk4wMnNX2t/C/ii7ZreWXSdUkOChG3e306E/Sp4vh4TIVu9XmeIdVjTaT+NDi1udrqU07y0ZgeF7R9W8XWgVQ0Fk3nzSdhxwp9816s4JLe5zUGk6VZ6PZC206EQxdWPUufUnvVwL61LOKvWVSWmyI1QEgHua8n8RynU/FGoyyMGMD/Z1XP3Avb+teuYxgjH0rzrxxpUmnau+pRqTYXZBkYf8s5Pf2NNIvCSSm77kXhrTVu5sMOF569a6e/0KB7NiqBGFcjpN+9lOJYiPw71q6h4lnurcxbUGSDuHb1p8prVjUc7x2OT1u2CJIR8skZ3Iw42kdDXq+hXjX+iadeOT5k0CM3ucYNeUzxzatex6dYr5lzcHaxHIRe7H2r2CztUs7S3tYseXBGsY464GM0PYWLa5Yp7kquRJy2exH+NeQarZyaPr93ZzZAZzNAx6OhOePcdK9fA6nHSs/WtGstatPs9/GWCnMcinDxn1BpIww9ZU5a7M84fUJ5IBGZCVwB68D/JpvhKzbV/FduyKWtbD97K/bf2X610S/DmJn2tq140OeUCgH6ZrrNG0W10WyFpp8IjhzkknLO3qT3o3OqeIpxi+Tdk/3iT3PNB/XvUmwqMEdPWmyZCkKCT0ApWPOuRsMk+vvTtsnof++ahvrmLStMuby4YtFbxliW5JxXmH/CzdZ/58IfzNVGm5am1OjOr8CuevD/WH6n+dRXv/AB5Xf/XJv5GiikzKHxI8b0X/AI9k/wCuf9a9N8Jf8eR+h/nRRVyPQxfwmV4y/wBc3+6KZ8N/+PvV/rF/I0UUU9mS/wCAyh4s/wCR1l/64R10nh3/AFLfj/I0UUuhNb+GvRGd4o/1yUfDb/mN/wDXZP8A0E0UVcOoP+Azrb7/AI8H/GuY0H/kJv8AWiitY/CcXQvfET/kVLr/AHk/9CFcQn+q/CiisJHoYf8Ah/Mi/iH1p0X+sj/3v6UUU0avZmj4j/5CDf8AXOP+VS6T/rk/3x/SiikzN/Abvi37p+lcHrf/AB7H/eH8xRRUvdBhfhR7An/HvF/uj+VNf/ln/vCiiqluea9yRfv1Ff8A3RRRVw3BbD7P/UCnn+tFFE9xs89+Kn/H/o//AG0/pXLL1f60UUn09D1cN/CX9dSpqH/Hm/8AuCvZdF/5Aenf9cU/lRRUv4TLG/DH+uxw3xf/AOPnSPq1csOr/wCe9FFOWyN8N/Cj8/zKuo/8sf8Arsv8694P3V+g/lRRQ/h+f+Rz437PzEP3Kd/AaKKzPPFPb61neJv+Rd1H/ri1FFDKpfGjx3Sf9Qn4f0q1P/qB/un+VFFansvc3Pg//wAf2qf7gr0f+99f6Ciiol1POxn8T5Dz9wfSiTp+NFFSjlRIn+r/AA/pWKv+ub6iiitqewmbUvQfSo06j6Giis3uN7nOfEH/AJEfUf8AdH868xoopv4Uergfgfqf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13046=[""].join("\n");
var outline_f12_47_13046=null;
var title_f12_47_13047="Orofacial clefts";
var content_f12_47_13047=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Types of orofacial clefts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 703px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13047=[""].join("\n");
var outline_f12_47_13047=null;
var title_f12_47_13048="Risk of anaphylaxis with plant food allergens";
var content_f12_47_13048=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F79719&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=16\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F79719&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=16\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 626px\">",
"   <div class=\"ttl\">",
"    Component resolved diagnostics of plant food allergens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 606px; height: 548px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The table shows how the component-resolved diagnostics can be used to estimate the risk of anaphylaxis (Ana) in a patient sensitized to various pollen-related plant allergens. Patients who are sensitized to allergens in the profilin and pathogenesis-related-protein-10 (PRP-10) groups (shown in green and purple) have a relatively low risk of anaphylaxis. Those sensitized to lipid transfer proteins (shown in orange) have an intermediate risk. The highest rate of anaphylaxis is observed in patient sensitized to more stable proteins that are not cross-reactive with pollen allergens, such as storage seed proteins, albumins, and globulins (shown in yellow). The specific allergens circled in red have been implicated in systemic reactions.",
"    <div class=\"footnotes\">",
"     * Reactive with birch tree pollen.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Reactive with timothy grass pollen.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13048=[""].join("\n");
var outline_f12_47_13048=null;
var title_f12_47_13049="Pharmacology of antiulcer medications";
var content_f12_47_13049=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pharmacology of antiulcer medications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13049/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13049/contributors\">",
"     Andrew H Soll, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13049/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13049/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13049/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13049/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/47/13049/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 19, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H23613455\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of peptic ulcers has changed dramatically in the past two decades, mirroring the revolution in understanding of the etiologies of peptic ulcers. Principles of treatment include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antibiotic therapy is indicated for Helicobacter pylori-positive ulcer disease.",
"     </li>",
"     <li>",
"      Anti-secretory drugs (H2 receptor antagonists [H2RAs] and proton pump inhibitors [PPIs]) are the mainstays of treatment for ulcer healing and maintenance of remission.",
"     </li>",
"     <li>",
"      Antacids,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"       bismuth",
"      </a>",
"      , and protective agents (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"       sucralfate",
"      </a>",
"      ) were shown to heal peptic ulcers in an era before the role of H. pylori was recognized, and, in retrospect, studies were performed on largely H. pylori-positive peptic ulcer patients. The efficacy of these agents for NSAID ulcers or for non-NSAID, non-H. pylori ulcers has not been established, and, thus, they have no role in the current treatment of peptic ulcers. The only exception is the use of bismuth as part of antibiotic regimens to cure H. pylori infection.",
"     </li>",
"     <li>",
"      Prostaglandin analogues (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      ) are effective for preventing NSAID-induced ulcers, but they have no established role for healing ulcers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The pharmacology of antiulcer drugs, excluding the antibiotics used to treat H. pylori, will be reviewed here. The treatment of H. pylori as well as an overview of the natural history and treatment of peptic ulcer disease are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=see_link\">",
"     \"Treatment regimens for Helicobacter pylori\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42281?source=see_link\">",
"     \"Overview of the natural history and treatment of peptic ulcer disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     H2 RECEPTOR ANTAGONISTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;H2 receptor antagonists (H2RAs) inhibit acid secretion by blocking histamine H2 receptors on the parietal cell (",
"    <a class=\"graphic graphic_figure graphicRef57131 \" href=\"UTD.htm?3/60/4047\">",
"     figure 1",
"    </a>",
"    ). Four H2RAs are used in the United States:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"       Cimetidine",
"      </a>",
"      (Tagamet&reg;)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"       Ranitidine",
"      </a>",
"      (Zantac&reg;)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/45/728?source=see_link\">",
"       Famotidine",
"      </a>",
"      (Pepcid&reg;)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/16/29958?source=see_link\">",
"       Nizatidine",
"      </a>",
"      (Axid&reg;)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These drugs are still used for treatment and maintenance therapy of peptic ulcer disease, treatment of gastroesophageal reflux disease, and management of dyspepsia. However, they achieve less acid suppression than proton pump inhibitors. The doses of the various H2RAs for the treatment of peptic ulcers are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef71477 \" href=\"UTD.htm?30/42/31403\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    H2RAs have comparable efficacy for inhibiting acid secretion and in healing peptic ulcers when used at appropriate doses. These agents remain useful in some patients because of their low cost and good safety profiles. In addition, less acid inhibition may be an advantage by avoiding the consequences of profound acid inhibition. Side effects of H2RAs do include rare, severe adverse events, such as renal and hepatic toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Absorption and distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;H2RAs are well absorbed after oral dosing; peak serum concentrations occur within one to three hours. Absorption is reduced 10 to 20 percent by concomitant antacid administration, but not by food.",
"   </p>",
"   <p>",
"    All four drugs cross the blood-brain and placental barriers and are excreted in breast milk [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1\">",
"     1",
"    </a>",
"    ]. The distribution of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    in cerebrospinal fluid appears to be increased in liver failure, suggesting that these patients are at increased risk of experiencing central nervous system (CNS) side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'CNS symptoms'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Hepatic and renal metabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;All four drugs are eliminated by a combination of hepatic and renal metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1\">",
"     1",
"    </a>",
"    ]. The bioavailability of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/45/728?source=see_link\">",
"     famotidine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    is reduced 30 to 60 percent by first pass hepatic metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1\">",
"     1",
"    </a>",
"    ]. By contrast,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/16/29958?source=see_link\">",
"     nizatidine",
"    </a>",
"    undergoes very little hepatic metabolism; its bioavailability following oral dosing is 100 percent. Similarly, the bioavailability with intravenous dosing of all H2RAs approaches 100 percent, suggesting that dose reductions are warranted with intravenous administration, depending upon the goals of treatment. The half-life of cimetidine is prolonged with liver failure, but dose reduction is probably only necessary if renal failure accompanies severe hepatic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Renal clearance of all four drugs is generally greater than accounted for by glomerular filtration, reflecting the importance of renal tubular secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1\">",
"     1",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     Cimetidine",
"    </a>",
"    and, to a much lesser degree,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    compete with creatinine for renal tubular secretion, causing a slight elevation in serum creatinine.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/16/29958?source=see_link\">",
"     Nizatidine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/45/728?source=see_link\">",
"     famotidine",
"    </a>",
"    have the greatest dependence upon renal clearance; their half-life is more prolonged with renal failure.",
"   </p>",
"   <p>",
"    Dose adjustments for renal failure are advised [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/3\">",
"     3",
"    </a>",
"    ]. The dose of all the H2RAs is generally reduced by 50 percent in patients with moderate to severe renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Reducing the dose appears to decrease adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The quantities of the H2 antagonists removed by peritoneal and hemodialysis are small; replacement doses are not necessary. Clearance is decreased in neonates and also in the elderly, suggesting that the dose should be reduced in individuals over age 75 years, particularly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;H2RAs are remarkably safe drugs; in randomized trials, the frequency of adverse reactions is generally similar to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/5\">",
"     5",
"    </a>",
"    ]. A number of uncommon side effects have been reported, primarily as isolated cases or in retrospective uncontrolled series. However, causality cannot be established from the temporal association between drug use and an untoward effect, particularly when the clinical situation is complicated by serious medical illness and the use of multiple drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/6\">",
"     6",
"    </a>",
"    ]. In addition, conclusions regarding causality can only be inferred with drug rechallenge, which is rarely performed. Thus, in the absence of controlled comparisons, only limited conclusions can be drawn regarding the relative occurrence of uncommon side effects with the H2RAs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Gynecomastia and impotence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gynecomastia and impotence occur with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    in a dose- and time-dependent fashion. Gynecomastia is rarely seen if treatment is limited to normal doses for eight weeks or less and, in one report, occurred in only 0.2 percent of men treated for 26 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/7\">",
"     7",
"    </a>",
"    ]. In another study, gynecomastia or impotence were noted in one-half of men with hypersecretory disorders taking prolonged, high-dose cimetidine therapy; these problems gradually resolved when",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    was used in place of cimetidine [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/8\">",
"     8",
"    </a>",
"    ]. Rare reports with other H2RA suggest that this effect is relatively specific for cimetidine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Immune and hematopoietic effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;H2RAs have been implicated in idiosyncratic cases of myelosuppression, thrombocytopenia, neutropenia, anemia, and pancytopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. Hemolytic anemia also has been reported, although no anti-drug antibodies or hemolysis upon rechallenge has been found [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/13\">",
"     13",
"    </a>",
"    ]. Concern persists that H2RAs may occasionally enhance transplant rejection and autoimmune or allergic diseases.",
"   </p>",
"   <p>",
"    Other uncommon reactions may be mediated by immune mechanisms. These include polymyositis and interstitial nephritis with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/6,14\">",
"     6,14",
"    </a>",
"    ], an immune complex rash with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    , and fever with both cimetidine and ranitidine [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some immunomodulatory effects may reflect a unique action of the imidazole ring of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    rather than actions at H2 receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/14\">",
"     14",
"    </a>",
"    ]. Comparative data with other H2RAs are limited and conflicting.",
"   </p>",
"   <p>",
"    Absorption of vitamin B12 depends upon gastric acid. As a result, it is not unexpected that long-term H2RA and proton pump inhibitor use has been associated with serum B12 deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/15\">",
"     15",
"    </a>",
"    ]. Although more data are needed, the possibility of B12 deficiency should be kept in mind in any patient on chronic acid suppression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     CNS symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;H2RAs have been suspected to cause confusion, restlessness, somnolence, agitation, headaches, and dizziness and, with prolonged therapy, hallucinations, focal twitching, seizures, unresponsiveness, and apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/6,16\">",
"     6,16",
"    </a>",
"    ]. Although these symptoms are generally reversible upon discontinuation of the drug, cases with more persistent CNS symptoms have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mental status changes appear to be most common in elderly patients in the intensive care unit who have comorbid renal or hepatic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/16\">",
"     16",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     Cimetidine",
"    </a>",
"    has been implicated as the most frequent cause of these CNS symptoms, but similar side effects have also been described with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/45/728?source=see_link\">",
"     famotidine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/6,16\">",
"     6,16",
"    </a>",
"    ]. CNS toxicity is rare during outpatient therapy. A study of H2RA effects on cognitive function among community dwelling elderly revealed a modest effect of borderline statistical significance [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/18\">",
"     18",
"    </a>",
"    ]. Ranitidine also may cause headaches [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/13,16\">",
"     13,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Hepatic dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient small increases in serum aminotransferases can occur with H2RAs, especially with high intravenous doses; these changes resolve during continued therapy. None of the four H2RAs is directly hepatotoxic; however, rare idiosyncratic or apparent immune hypersensitivity hepatitis, characterized by rash, fever,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    eosinophilia, can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/2,19\">",
"     2,19",
"    </a>",
"    ]. The acute hepatitis is rapidly reversible after withdrawal of the drug. The pathological picture has included cholestatic, hepatocellular, and mixed reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/20\">",
"     20",
"    </a>",
"    ]. Hepatotoxicity has recurred with rechallenge in a sufficient number of cases to firmly establish this rare, but important association [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serial monitoring of liver chemistries is",
"    <strong>",
"     not",
"    </strong>",
"    justified since these events are uncommon and the causality is uncertain. Nevertheless, checking hepatic enzymes approximately five days into high dose intravenous therapy is probably warranted. If hepatitis does develop in a patient receiving an H2RA, the drug should be immediately discontinued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Cardiac effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;H2 receptors are present in the heart. Sinus bradycardia, hypotension, atrioventricular block, prolongation of the QT interval, and sinus and cardiac arrest have occurred with the rapid infusion of an H2RA [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1,21,22\">",
"     1,21,22",
"    </a>",
"    ]. Oral therapy also has been reported to cause cardiac toxicity, although clinically significant effects upon sinus rhythm or conduction are rare. Possible risk factors for cardiac events include rapid intravenous infusion, high dose, conditions that would delay drug clearance (eg, renal or hepatic dysfunction), and underlying cardiac disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Renal effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild increases in serum creatinine have been observed with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    . However, clinically significant renal disease appears to be limited to immune-mediated interstitial nephritis. A review published in 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/20\">",
"     20",
"    </a>",
"    ] identified 25 published reports of acute interstitial nephritis with H2RA and an additional 16 cases in the Australian Adverse Drug Reaction Advisory Committee (ADRAC) database [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/20\">",
"     20",
"    </a>",
"    ]. Renal biopsy and rechallenge have confirmed a sufficient number of cases to substantiate this rare association. Onset ranged from 1 day to 11 months after initiation of therapy. The clinical presentation was nonspecific, including sterile pyuria, proteinuria, leukocytosis, elevated erythrocyte sedimentation rate, and fatigue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Drug interactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug interactions have been described with some of the H2 receptor antagonists, particularly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    . Thus, considering potential interactions is important when prescribing H2 receptor antagonists or adding medications to patients already taking them. (See",
"    <a class=\"drug drug_patient\" href=\"UTD.htm?26/30/27109?source=see_link\">",
"     \"Cimetidine: Patient drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Teratogenicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data remain limited, there is no evidence of major teratogenic effects with H2RAs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PROTON PUMP INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proton pump inhibitors (PPIs)",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"     omeprazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/14/3305?source=see_link\">",
"     lansoprazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/9/27799?source=see_link\">",
"     dexlansoprazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/18/44327?source=see_link\">",
"     rabeprazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32009?source=see_link\">",
"     pantoprazole",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/39/15993?source=see_link\">",
"     esomeprazole",
"    </a>",
"    effectively block acid secretion by irreversibly binding to and inhibiting the hydrogen-potassium ATPase pump that resides on the luminal surface of the parietal cell membrane (",
"    <a class=\"graphic graphic_figure graphicRef57131 \" href=\"UTD.htm?3/60/4047\">",
"     figure 1",
"    </a>",
"    ). There are three phases of their action:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      They are weak bases that are concentrated in the acidic compartments of the parietal cell",
"     </li>",
"     <li>",
"      Once there, the inactive prodrug is activated by the acid environment",
"     </li>",
"     <li>",
"      A reactive sulfhydryl group then forms a disulfide bond with a cysteine residue on the H-K-ATPase pump, thereby inactivating the enzyme",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acidic compartments within the stimulated parietal cell are essential for activation of a PPI; in other words, the parietal cell has to be active in order to be inhibited by PPIs. Thus, PPIs work poorly in fasting patients or in those receiving simultaneous dosing with other antisecretory agents (H2 receptor antagonists, anticholinergic agents,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    , or somatostatin). If the parietal cell is inhibited in the six hours following PPI dosing, PPI efficacy will be compromised. PPIs are most effective when taken 30 to 60 minutes before meals so that they are in the bloodstream in the few post-prandial hours when parietal cells are stimulated.",
"   </p>",
"   <p>",
"    PPIs all achieve a similar level of acid secretory inhibition, although small differences in efficacy have been demonstrated when comparing various agents given in standard clinical doses. For example,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/39/15993?source=see_link\">",
"     esomeprazole",
"    </a>",
"    was slightly more effective than other delayed release PPIs in healing of esophagitis. Slightly superior healing has also been demonstrated with immediate release",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"     omeprazole",
"    </a>",
"    compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/14/3305?source=see_link\">",
"     lansoprazole",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32009?source=see_link\">",
"     pantoprazole",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/28/25034?source=see_link\">",
"     \"Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, differences in healing rates with various PPIs observed in clinical trials of esophagitis have not been demonstrated in the treatment of peptic ulcer disease. As a result, our approach is based upon clinical experience and the pharmacology of these drugs. If a standard PPI therapy fails to heal an ulcer, we proceed with twice daily dosing, and if that treatment fails, we switch to another PPI.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/39/15993?source=see_link\">",
"     Esomeprazole",
"    </a>",
"    or immediate-release",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"     omeprazole",
"    </a>",
"    may be more effective than other PPIs. Immediate release omeprazole taken at bedtime also appears to be superior to delayed release PPIs taken before dinner [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/25\">",
"     25",
"    </a>",
"    ]; this regimen may have some advantage for refractory ulcers. A complete discussion of the pharmacology and clinical efficacy of the PPIs is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/28/25034?source=see_link\">",
"     \"Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The safety of PPIs is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/28/25034?source=see_link&amp;anchor=H59974871#H59974871\">",
"     \"Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders\", section on 'Safety'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     COMPARATIVE EFFICACY OF ANTISECRETORY AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proton pump inhibitors (PPIs) are more effective and long-lasting acid inhibitors than H2 receptor antagonists (H2RAs). As a result, they are superior in healing both gastric and duodenal ulcers, although the advantage for gastric ulcers is modest [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Although H2RAs are less potent inhibitors of gastric acid secretion with a longer duration of treatment, ulcer healing rates appear comparable to PPIs for uncomplicated ulcers. The clearest advantages for PPIs over H2RAs are as components of H. pylori antibiotic regimens and for treatment of hypersecretory states, such as gastrinoma and probably refractory ulcers.",
"   </p>",
"   <p>",
"    Treatment needs to be adapted to the individual patient. H2RA-mediated acid inhibition is limited by tolerance, which is variable among subjects and likely contributes to poor efficacy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29160?source=see_link\">",
"     \"Physiology of gastric acid secretion\"",
"    </a>",
"    .) Tolerance does not occur for PPIs, but variable metabolism does account for some difference in efficacy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/28/25034?source=see_link\">",
"     \"Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ANTACIDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability of antacids containing aluminum and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/6/31847?source=see_link\">",
"     magnesium hydroxide",
"    </a>",
"    to heal ulcers was established in an era when most ulcers were H. pylori positive. The administered antacid buffering capacity poorly predicts ulcer healing, suggesting that healing is related not only to neutralization of gastric acid but also to other actions. In addition, in animal models, antacids protect the gastric mucosa against acute chemical injury independent of their effects on buffering acid.",
"   </p>",
"   <p>",
"    The following are hypothesized mechanisms for the acid-independent actions of antacids [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/16/27910?source=see_link\">",
"       Aluminum hydroxide",
"      </a>",
"      binds growth factors and enhances their binding to experimental ulcers, possibly serving to deliver growth factors to injured mucosa.",
"     </li>",
"     <li>",
"      Antacids promote angiogenesis in injured mucosa [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antacids bind bile acids and also inhibit peptic activity [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Heavy metals are well known to suppress, but generally not eradicate, H. pylori.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is unclear which, if any, of these actions facilitate peptic ulcer healing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antacid side effects depend upon the quantity consumed and the duration of therapy. Magnesium containing antacids cause diarrhea and hypermagnesemia; the latter only becomes important in patients with renal insufficiency. Antacids may also contain considerable sodium and volume overload can occur in susceptible patients.",
"   </p>",
"   <p>",
"    Ingestion of large amounts of calcium and absorbable alkali, particularly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    , can lead to hypercalcemia, alkalosis, and renal impairment, a constellation known as the milk-alkali syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27094?source=see_link\">",
"     \"The milk-alkali syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are also potential adverse effects related to excessive aluminum absorption, which are discussed below. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Aluminum toxicity'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUCRALFATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     Sucralfate",
"    </a>",
"    (Carafate&reg;) is a sulfated polysaccharide, sucrose octasulfate, complexed with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/16/27910?source=see_link\">",
"     aluminum hydroxide",
"    </a>",
"    . It prevents acute chemically-induced mucosal damage and heals chronic ulcers without altering gastric acid or pepsin secretion or significantly buffering acid [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/28,33\">",
"     28,33",
"    </a>",
"    ]. Similar to aluminum-containing antacids, sucralfate stimulates angiogenesis and the formation of granulation tissue, possibly due to growth factor binding [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/28\">",
"     28",
"    </a>",
"    ]. Sucralfate also binds to the injured tissue, thereby delivering growth factors and reducing access to pepsin and acid.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/16/27910?source=see_link\">",
"     Aluminum hydroxide",
"    </a>",
"    mediates some of the actions of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    , but the sucrose octasulfate moiety may also have a role by contributing sulfhydryl groups to reduce oxidant damage to epithelial cells. The binding of this agent to the ulcer base is enhanced at a pH below 3.5, leading to the recommendation that the drug be administered 30 to 60 minutes before meals.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     Sucralfate",
"    </a>",
"    has been reported to suppress H. pylori and inhibit acid secretion in infected patients with duodenal ulcers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/34\">",
"     34",
"    </a>",
"    ]. No data are available to test the relevance of this action by comparing ulcer healing in patients with H. pylori-positive versus -negative duodenal ulcer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     Sucralfate",
"    </a>",
"    has minimal adverse effects other than possible aluminum toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/33\">",
"     33",
"    </a>",
"    ]. It can bind other drugs if taken simultaneously, although the clinical consequences are minor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Aluminum toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant absorption of aluminum occurs with several antacid formulations and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/35\">",
"     35",
"    </a>",
"    ]. Daily consumption of 120 mmol of aluminum-containing antacid tablets for four weeks increases serum and urinary aluminum levels [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/36\">",
"     36",
"    </a>",
"    ]. A therapeutic dose of sucralfate contains about 0.8 g of aluminum and the aluminum absorption is comparable to that seen with antacids [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aluminum is readily excreted by normal kidneys; urinary levels are elevated for one to three weeks after discontinuing therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. By comparison, significant aluminum retention occurs in patients with renal failure, and may result in neurotoxicity and anemia following treatment with either antacids or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/4,39,41\">",
"     4,39,41",
"    </a>",
"    ]. As a result,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    or acetate, rather than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/16/27910?source=see_link\">",
"     aluminum hydroxide",
"    </a>",
"    is now the primary agent used to bind dietary phosphate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5352?source=see_link\">",
"     \"Aluminum toxicity in end-stage renal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=see_link\">",
"     \"Treatment of hyperphosphatemia in chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Simultaneous consumption of citrate enhances absorption of aluminum 50-fold in patients with normal renal function, resulting in considerable elevations in serum aluminum concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/36,42\">",
"     36,42",
"    </a>",
"    ]. To avoid enhanced aluminum absorption, especially in the setting of renal failure, it is advisable to avoid combining antacids and probably",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    with foods or other agents that contain citrate. If necessary to correct metabolic acidosis, alkali should be given as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    , not sodium citrate.",
"   </p>",
"   <p>",
"    The extent and consequences of aluminum deposition in tissues with sustained use of either class of agents have not been defined; the possibility of significant aluminum retention in the face of normal renal function is remote. Aluminum deposits have been reported in brain tissue in Alzheimer disease, but evidence points against significant aluminum deposition in the brain or a role for this metal in the pathogenesis of this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. Nevertheless, more rigorous investigation of tissue aluminum is required in humans before firm conclusions can be reached.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/16/27910?source=see_link\">",
"     Aluminum hydroxide",
"    </a>",
"    blocks intestinal absorption of phosphate; two weeks of therapy with moderate doses can result in significant hypophosphatemia, especially if the patient is on a low phosphate diet or is phosphate-depleted for other reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/46\">",
"     46",
"    </a>",
"    ].&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     Sucralfate",
"    </a>",
"    also binds phosphate leading to similar theoretical consequences; combining sucralfate and antacids can potentially amplify these effects [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15767?source=see_link\">",
"     \"Causes of hypophosphatemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     BISMUTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several forms of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    were used for ulcer treatment long before the role of H. pylori was recognized. Currently, colloidal bismuth subcitrate (CBS), also known as tri-potassium di-citrato bismuthate (De-Nol), and bismuth subsalicylate (BSS, Pepto-Bismol) are used in treatment of H. pylori infection.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     Bismuth",
"    </a>",
"    subsalicylate is available in the United States either as Pepto-Bismol or Helidac, the latter in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    . Helidac is approved in the United States for treatment of H. pylori-associated duodenal ulcer. However, to more effectively cure H. pylori and to ensure ulcer healing, it should be combined with twice daily proton pump inhibitor treatment. Furthermore, the metronidazole dose in Helidac is only 1 gram daily, which is too low to be effective in the face of metronidazole resistance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=see_link\">",
"     \"Treatment regimens for Helicobacter pylori\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most dramatic action of these",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    salts is the suppression of H. pylori [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/47\">",
"     47",
"    </a>",
"    ]. Bismuth is not effective in H. pylori-negative ulcers, suggesting the healing efficacy of bismuth primarily reflects suppression of the infection. However, there are numerous studies from the pre-H. pylori era suggesting that bismuth also has other actions that may promote ulcer healing, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inhibition of peptic activity but not pepsin secretion [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/48\">",
"       48",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"       Bismuth",
"      </a>",
"      from CBS may bind to ulcer craters [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Macrophages, recruited to the edge of the ulcer crater in CBS-treated rats, may promote healing [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/49\">",
"       49",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      CBS may increase mucosal prostaglandin production, and mucus and bicarbonate secretion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     Bismuth",
"    </a>",
"    does not inhibit or neutralize gastric acid.",
"   </p>",
"   <p>",
"    The subsalicylate salt of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    has received too little study to determine its antiulcer properties [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/47,51\">",
"     47,51",
"    </a>",
"    ]. In the colon, bismuth salts react with hydrogen sulfide to form bismuth sulfide, which blackens the stools [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary concern with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    compounds is bismuth intoxication; this was a problem primarily when bismuth subgallate was used for prolonged periods at high doses. Bismuth absorption varies with the specific form of bismuth; absorption is much greater with CBS than with BSS or bismuth subnitrate [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Coadministration of H2 receptor antagonists increases bismuth absorption from CBS, but not from BSS or bismuth subnitrate [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/54\">",
"     54",
"    </a>",
"    ]. Nevertheless, significant clinical toxicity has not been reported in clinical trials with CBS or BSS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/47,55\">",
"     47,55",
"    </a>",
"    ]. Bismuth should be avoided or serum bismuth concentrations monitored in patients with renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The subsalicylate moiety in BSS is converted to salicylic acid and absorbed; however, salicylate in the absence of the acetyl group does not inhibit platelet function or appear to share the same high risk of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    for gastrointestinal bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/56-59\">",
"     56-59",
"    </a>",
"    ]. However, the salicylate from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    subsalicylate will contribute to serum salicylate levels and cause salicylate toxicity, and combination with other salicylate products should therefore be avoided.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PROSTAGLANDINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prostaglandins, particularly of the E and I group, inhibit acid secretion by selectively reducing the ability of the parietal cell to generate cyclic AMP in response to histamine [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/60\">",
"     60",
"    </a>",
"    ]. Prostaglandins also enhance mucosal defense mechanisms.",
"   </p>",
"   <p>",
"    While several prostanoids have been tested for peptic ulcer healing, only",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    (Cytotec&reg;) has been approved for use in the United States, and not for ulcer healing but rather for prevention of NSAID-induced gastric ulcer. Misoprostol is a 15-deoxy-15-hydroxy-16-methyl analogue of prostaglandin E1. Topical action appears critical for prostaglandin action; oral administration of misoprostol gives greater antisecretory efficacy and fewer side effects than systemic administration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most frequent side effects of the E type prostanoids are dose-dependent crampy abdominal pain and diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. These side effects interfere with compliance in many patients. The problem of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    -induced diarrhea has been addressed in several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Educate the patient to anticipate and manage mild, usually transient cramps and diarrhea, but to stop the drug for more persistent or troublesome problems",
"     </li>",
"     <li>",
"      The patient should be instructed not to use concomitant cathartic agents, to stop stool softeners unless absolutely necessary, and then to reevaluate the need for these agents after several weeks of therapy",
"     </li>",
"     <li>",
"      The dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      should begin at 100 micrograms three to four times daily, then increased to a maximal daily dose of 800 micrograms as tolerated",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lower doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    have been used with some success for ulcer prevention with a lower incidence of side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38393?source=see_link\">",
"     \"NSAIDs (including aspirin): Primary prevention of gastroduodenal toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prostaglandins of the E group are uterotropic.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     Misoprostol",
"    </a>",
"    has been given with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/45/1753?source=see_link\">",
"     mifepristone",
"    </a>",
"    to induce abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13049/abstract/62,65\">",
"     62,65",
"    </a>",
"    ]. As a result,",
"    <strong>",
"     it is contraindicated in women of childbearing potential who are not on contraception",
"    </strong>",
"    . All patients should be informed of this risk to minimize the drug being inadvertently given by the patient to a pregnant woman.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mainstay of ulcer treatment, apart from curing H. pylori and withdrawing NSAIDs, is the administration of antisecretory drugs of the H2 receptor antagonist (H2RA) and proton pump inhibitor classes.",
"     </li>",
"     <li>",
"      H2RAs inhibit acid secretion by blocking histamine H2 receptors on the parietal cell (",
"      <a class=\"graphic graphic_figure graphicRef57131 \" href=\"UTD.htm?3/60/4047\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'H2 receptor antagonists'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The proton pump inhibitors effectively block acid secretion by irreversibly binding to and inhibiting the hydrogen-potassium ATPase pump that resides on the luminal surface of the parietal cell membrane (",
"      <a class=\"graphic graphic_figure graphicRef57131 \" href=\"UTD.htm?3/60/4047\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Proton pump inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although antacids and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"       sucralfate",
"      </a>",
"      induce ulcer healing, at present there is no clear role for their use in ulcer treatment. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Sucralfate'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Colloidal",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"       bismuth",
"      </a>",
"      preparations also induce ulcer healing but their only role now for ulcer treatment is as part of antibiotic regimens for curing H. pylori. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Bismuth'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several prostanoid analogues enhance peptic ulcer healing; only",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      has been approved for use in the United States for prevention, but not treatment, of NSAID-induced gastric ulcers. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Prostaglandins'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/1\">",
"      Feldman M, Burton ME. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 1. N Engl J Med 1990; 323:1672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/2\">",
"      Lewis JH. Hepatic effects of drugs used in the treatment of peptic ulcer disease. Am J Gastroenterol 1987; 82:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/3\">",
"      Manlucu J, Tonelli M, Ray JG, et al. Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence. Nephrol Dial Transplant 2005; 20:2376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/4\">",
"      Gladziwa U, Koltz U. Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure. Clin Pharmacokinet 1994; 27:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/5\">",
"      Reynolds JC. The clinical importance of drug interactions with antiulcer therapy. J Clin Gastroenterol 1990; 12 Suppl 2:S54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/6\">",
"      Smallwood RA, Berlin RG, Castagnoli N, et al. Safety of acid-suppressing drugs. Dig Dis Sci 1995; 40:63S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/7\">",
"      McCarthy DM. Ranitidine or cimetidine. Ann Intern Med 1983; 99:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/8\">",
"      Jensen RT, Collen MJ, Pandol SJ, et al. Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. N Engl J Med 1983; 308:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/9\">",
"      Potter HP Jr, Byrne EB, Lebovitz S. Fever after cimetidine and ranitidine. J Clin Gastroenterol 1986; 8:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/10\">",
"      Nakano T, Kuroiwa T, Tsumita Y, et al. Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient. Clin Exp Nephrol 2004; 8:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/11\">",
"      Takami N, Yamamoto Y, Matsuo H, et al. Agranulocytosis possibly caused by ranitidine in a patient with renal failure. Int J Clin Pharmacol Ther 2002; 40:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/12\">",
"      Ecker RD, Wijdicks EF, Wix K, McClelland R. Does famotidine induce thrombocytopenia in neurosurgical patients? J Neurosurg Anesthesiol 2004; 16:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/13\">",
"      Feldman M, Burton ME. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2). N Engl J Med 1990; 323:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/14\">",
"      Kumar A. Cimetidine: an immunomodulator. DICP 1990; 24:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/15\">",
"      Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol 2004; 57:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/16\">",
"      Cant&uacute; TG, Korek JS. Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med 1991; 114:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/17\">",
"      von Einsiedel RW, Roesch-Ely D, Diebold K, et al. H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures. Pharmacopsychiatry 2002; 35:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/18\">",
"      Hanlon JT, Landerman LR, Artz MB, et al. Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly. Pharmacoepidemiol Drug Saf 2004; 13:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/19\">",
"      Black M. Hepatotoxic and hepatoprotective potential of histamine (H2)-receptor antagonists. Am J Med 1987; 83:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/20\">",
"      Fisher AA, Le Couteur DG. Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists. Drug Saf 2001; 24:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/21\">",
"      Hinrichsen H, Halabi A, Kirch W. Clinical aspects of cardiovascular effects of H2-receptor antagonists. Eur J Clin Invest 1995; 25 Suppl 1:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/22\">",
"      Lee KW, Kayser SR, Hongo RH, et al. Famotidine and long QT syndrome. Am J Cardiol 2004; 93:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/23\">",
"      Garbis H, Elefant E, Diav-Citrin O, et al. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services. Reprod Toxicol 2005; 19:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/24\">",
"      Howden CW, Ballard ED, Koch FK, et al. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD. J Clin Gastroenterol 2009; 43:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/25\">",
"      Katz PO, Koch FK, Ballard ED, et al. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. Aliment Pharmacol Ther 2007; 25:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/26\">",
"      Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/27\">",
"      Howden CW, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther 1990; 4:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/28\">",
"      Tarnawski A, Tanoue K, Santos AM, Sarfeh IJ. Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment? Scand J Gastroenterol Suppl 1995; 210:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/29\">",
"      Konturek SJ. New aspects of clinical pharmacology of antacids. J Physiol Pharmacol 1993; 44:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/30\">",
"      Tarnawski A, Hollander D, Gergely H. Antacids: new perspectives in cytoprotection. Scand J Gastroenterol Suppl 1990; 174:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/31\">",
"      Weberg R, Berstad K, Berstad A. Acute effects of antacids on gastric juice components in duodenal ulcer patients. Eur J Clin Invest 1990; 20:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/32\">",
"      Orwoll ES. The milk-alkali syndrome: current concepts. Ann Intern Med 1982; 97:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/33\">",
"      Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991; 114:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/34\">",
"      Banerjee S, El-Omar E, Mowat A, et al. Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology 1996; 110:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/35\">",
"      Kaehny WD, Hegg AP, Alfrey AC. Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med 1977; 296:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/36\">",
"      Berstad, A, Weberg, R. Antacids for peptic ulcer: Do we have anything better? Scand J Gastroenterol 1986; 21(Suppl 125):32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/37\">",
"      Haram EM, Weberg R, Berstad A. Urinary excretion of aluminium after ingestion of sucralfate and an aluminium-containing antacid in man. Scand J Gastroenterol 1987; 22:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/38\">",
"      Allain P, Mauras Y, Krari N, et al. Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate. Br J Clin Pharmacol 1990; 29:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/39\">",
"      Robertson JA, Salusky IB, Goodman WG, et al. Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis. Ann Intern Med 1989; 111:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/40\">",
"      Chines A, Pacifici R. Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature. Calcif Tissue Int 1990; 47:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/41\">",
"      Arieff AI, Cooper JD, Armstrong D, Lazarowitz VC. Dementia, renal failure, and brain aluminum. Ann Intern Med 1979; 90:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/42\">",
"      Walker JA, Sherman RA, Cody RP. The effect of oral bases on enteral aluminum absorption. Arch Intern Med 1990; 150:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/43\">",
"      Katzman R. Alzheimer's disease. N Engl J Med 1986; 314:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/44\">",
"      Sherrard DJ. Aluminum--much ado about something. N Engl J Med 1991; 324:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/45\">",
"      Flaten TP, Glattre E, Viste A, S&oslash;oreide O. Mortality from dementia among gastroduodenal ulcer patients. J Epidemiol Community Health 1991; 45:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/46\">",
"      Shields HM. Rapid fall of serum phosphorus secondary to antacid therapy. Gastroenterology 1978; 75:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/47\">",
"      Gorbach SL. Bismuth therapy in gastrointestinal diseases. Gastroenterology 1990; 99:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/48\">",
"      Baron JH, Barr J, Batten J, et al. Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol). Gut 1986; 27:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/49\">",
"      Koo J, Ho J, Lam SK, et al. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat. Gastroenterology 1982; 82:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/50\">",
"      Elder JB. Recent experimental and clinical studies on the pharmacology of colloidal bismuth subcitrate. Scand J Gastroenterol Suppl 1986; 122:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/51\">",
"      Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/52\">",
"      Nwokolo CU, Gavey CJ, Smith JT, Pounder RE. The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1989; 3:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/53\">",
"      Nwokolo, CU, Prewett, EJ, Sawyer, AM, et al. Lack of bismuth absorption from bismuth subnitrate (Roter) tablets. Eur J Gastroenterol Hepatol 1990; 2:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/54\">",
"      Nwokolo CU, Prewett EJ, Sawyerr AM, et al. The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds. Gastroenterology 1991; 101:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/55\">",
"      Wagstaff AJ, Benfield P, Monk JP. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs 1988; 36:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/56\">",
"      Sweeney JD, Hoernig LA. Hemostatic effects of salsalate in normal subjects and patients with hemophilia A. Thromb Res 1991; 61:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/57\">",
"      Danesh BJ, McLaren M, Russell RI, et al. Comparison of the effect of aspirin and choline magnesium trisalicylate on thromboxane biosynthesis in human platelets: role of the acetyl moiety. Haemostasis 1989; 19:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/58\">",
"      Cohen A. Fecal blood loss and plasma salicylate study of salicylsalicylic acid and aspirin. J Clin Pharmacol 1979; 19:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/59\">",
"      Torgy&aacute;n S, Ady E, Wagner L, et al. Reduction of indomethacin-induced gastrointestinal blood loss by sodium salicylate in man. Int J Clin Pharmacol Biopharm 1978; 16:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/60\">",
"      Chen MC, Amirian DA, Toomey M, et al. Prostanoid inhibition of canine parietal cells: mediation by the inhibitory guanosine triphosphate-binding protein of adenylate cyclase. Gastroenterology 1988; 94:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/61\">",
"      Feldman M. Prostaglandins and gastric ulcers: from seminal vesicle to misoprostol (Cytotec). Am J Med Sci 1990; 300:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/62\">",
"      Bianchi Porro G, Parente F. Side effects of anti-ulcer prostaglandins: an overview of the worldwide clinical experience. Scand J Gastroenterol Suppl 1989; 164:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/63\">",
"      Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988; 2:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/64\">",
"      Raskin JB, White RH, Jackson JE, et al. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 1995; 123:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13049/abstract/65\">",
"      el-Refaey H, Rajasekar D, Abdalla M, et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332:983.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 32 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-190.102.30.19-CBD0E914AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13049=[""].join("\n");
var outline_f12_47_13049=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23613455\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      H2 RECEPTOR ANTAGONISTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Absorption and distribution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Hepatic and renal metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Gynecomastia and impotence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Immune and hematopoietic effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - CNS symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Hepatic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Cardiac effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Renal effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Drug interactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Teratogenicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PROTON PUMP INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      COMPARATIVE EFFICACY OF ANTISECRETORY AGENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ANTACIDS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUCRALFATE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Aluminum toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      BISMUTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PROSTAGLANDINS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/32\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/32|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/60/4047\" title=\"figure 1\">",
"      Actions antiulcer drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/32|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/42/31403\" title=\"table 1\">",
"      H2 receptor antagonists",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5352?source=related_link\">",
"      Aluminum toxicity in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15767?source=related_link\">",
"      Causes of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?26/30/27109?source=related_link\">",
"      Cimetidine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38393?source=related_link\">",
"      NSAIDs (including aspirin): Primary prevention of gastroduodenal toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/28/25034?source=related_link\">",
"      Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42281?source=related_link\">",
"      Overview of the natural history and treatment of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29160?source=related_link\">",
"      Physiology of gastric acid secretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27094?source=related_link\">",
"      The milk-alkali syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=related_link\">",
"      Treatment of hyperphosphatemia in chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=related_link\">",
"      Treatment regimens for Helicobacter pylori",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_47_13050="Evaluation of earache in children";
var content_f12_47_13050=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of earache in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13050/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13050/contributors\">",
"     David Greenes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13050/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13050/contributors\">",
"     Gary R Fleisher, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/47/13050/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/47/13050/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/47/13050/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ear pain (or otalgia) ranks as one of the leading complaints among children evaluated in the primary care or emergency setting. Most patients will have one of three common diagnoses (acute otitis media, otitis externa, or otitis media with effusion) which are generally not serious. The rare cases of more serious disease associated with ear pain usually result from extension of ear infection to adjacent anatomic structures (eg, mastoiditis, meningitis, malignant otitis externa, venous sinus thrombosis). Basilar skull fracture or epidural hematoma after head trauma may also present with ear pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of ear pain can be categorized by the anatomic site from which the pain originates (",
"    <a class=\"graphic graphic_table graphicRef60554 \" href=\"UTD.htm?29/11/29885\">",
"     table 1",
"    </a>",
"    ). Patients with primary otalgia have pain originating from the ear itself. Secondary otalgia is referred pain, originating in another anatomic site but causing the sensation of arising from the ear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Auricle",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Contusion (auricular hematoma)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt trauma to the external ear may result in contusions of the auricle. Physical findings may include swelling, ecchymosis, and tenderness overlying the auricle. Lacerations to the ear may also occur. Care should be taken to evaluate for lacerations involving the perichondrium or cartilage itself, which will require a layered repair and present an increased risk of infection.",
"   </p>",
"   <p>",
"    Auricular hematomas are localized collections of subperichondrial blood that typically result either from blunt impact or from friction, as commonly occurs during wrestling [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/1\">",
"     1",
"    </a>",
"    ]. Shearing of the perichondrium away from the underlying cartilage results in rupture of the subperichondrial blood vessels. The hematomas are typically found in the anterior superior part of the auricle and present as a fluctuant, purple or red, mildly tender mass. Hematoma drainage followed by careful pressure bandaging of the auricle to prevent reaccumulation of the hematoma is essential to optimal cosmetic outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Cellulitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cellulitis of the auricle frequently develops after trauma, an insect bite, or an ear piercing. Patients present with fairly rapid onset and progression of pain, redness, swelling, tenderness, and induration. In some cases, the swollen auricle will appear to protrude outward.",
"   </p>",
"   <p>",
"    Perichondritis is an infection of the perichondrium, the thin fascial layer surrounding the auricular cartilage. Perichondritis may result from blunt trauma or from piercings. Infection involving the cartilage can lead to permanent deformity of the ear, so perichondritis must be recognized and treated promptly. With perichondritis, the cartilaginous portion of the ear is red, swollen, and tender, but the ear lobe &ndash; which contains no cartilage &ndash; may be spared. Often, there is a focal area of fluctuance, indicating subperichondrial abscess that requires drainage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32503?source=see_link&amp;anchor=H16#H16\">",
"     \"Other Pseudomonas aeruginosa infections\", section on 'Perichondritis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Herpes zoster oticus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Herpes zoster oticus describes a reactivation of the varicella (chickenpox) virus after prior varicella infection that involved the skin of the external ear. Burning pain, hyperesthesia, and pruritus may precede the onset of vesicular lesions, making early diagnosis a challenge [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/2\">",
"     2",
"    </a>",
"    ]. Vesicular lesions may be seen on the pinna or in the ear canal. Associated inner ear dysfunction (hearing loss or vertigo) or facial weakness (the Ramsay Hunt syndrome) may occur. This syndrome is rare in young children, especially in the era of universal varicella vaccination, but it may be seen occasionally in adolescents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'Ramsay Hunt syndrome (Herpes zoster oticus)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Allergic angioedema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic swelling of the external ear may result from local allergic reactions to insect bites or from contact dermatitis (as with poison ivy). There is usually prominent pruritus and little if any pain, induration, or tenderness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15641?source=see_link\">",
"     \"An overview of angioedema: Clinical features, diagnosis, and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Environmental injuries to the ear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Frostbite or sunburn can also cause redness, swelling, and pain of the auricle. Typically, there will be a history of environmental exposure to suggest the diagnosis. Often, there will be bilateral ear involvement, which is atypical of most infections or local allergic reactions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37671?source=see_link&amp;anchor=H7#H7\">",
"     \"Frostbite\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30136?source=see_link\">",
"     \"Sunburn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ear canal",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Otitis externa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otitis externa refers to diffuse infection of the external ear canal, typically caused by Pseudomonas aeruginosa, Staphylococcus aureus, or occasionally other gram-negative rods. Otitis externa usually results from the introduction of water into the ear canal as a result of swimming. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26816?source=see_link\">",
"     \"Patient information: External otitis (including swimmer's ear) (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cardinal symptom of acute otitis externa is pain and tenderness localized to the auditory meatus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/3\">",
"     3",
"    </a>",
"    ]. There may also be pain with jaw movement, a feeling of fullness in the ear, itching of the ear canal, or discharge from the canal. Fever is rare. On physical examination, most patients will have tenderness of the tragus and pain with otoscopy. The ear canal may appear swollen, red, or macerated. A thick and sometimes malodorous discharge may be present. The tympanic membrane (TM) may appear red, but in cases of isolated otitis externa, there should be no fluid behind the TM.",
"   </p>",
"   <p>",
"    Fungal otitis externa (caused by Aspergillus or Candida) can occur, especially if the normal bacterial milieu of the ear canal has been eradicated by extensive use of topical antimicrobial agents. Fungal otitis externa is characterized by itch more than pain. White flaky debris may be seen in the ear canal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link&amp;anchor=H21#H21\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\", section on 'Otomycosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Malignant otitis externa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant otitis externa occurs when infection spreads from the ear canal to the surrounding bones of the skull base [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/4\">",
"     4",
"    </a>",
"    ]. This condition is quite rare in pediatrics but may occur in patients with immunocompromise. Patients with malignant otitis externa typically have a more intense and deep-seated ear pain, systemic signs of toxicity or fever, and possibly tenderness of the temporal bone or facial nerve palsy. The diagnosis is suggested by elevated inflammatory markers (ESR or CRP) and confirmed by cranial imaging (CT or MRI) indicating osteomyelitis of the skull base. Pseudomonas aeruginosa is the usual pathogen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20216?source=see_link\">",
"     \"Malignant (necrotizing) external otitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Contact dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of topical antimicrobial or analgesic drops may result in a contact dermatitis of the external ear. A pink-red confluent, slightly bumpy rash may be noted in the ear canal, in the concha, or on the surrounding skin. Itch is more prominent than pain, and discharge is uncommon. Atopic dermatitis (eczema) of the ear canal may cause similar findings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26104?source=see_link\">",
"     \"Contact dermatitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Furuncle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Furunculosis is a localized skin infection involving one or more hair follicles of the outer ear canal, typically caused by Staphylococcus aureus. Patients with furunculosis have focal pain and a red, swollen, tender mass in the external canal. There is typically no swelling of the pinna, ear discharge, fever, or adjacent adenopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link&amp;anchor=H5#H5\">",
"     \"Skin abscesses, furuncles, and carbuncles\", section on 'Furuncles and carbuncles'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Foreign body",
"    </span>",
"    &nbsp;&mdash;&nbsp;Foreign bodies in the ear canal usually present with a suggestive history, but sometimes ear pain or hearing loss may be the chief complaint. Foreign bodies that have been present for some length of time may be obscured by surrounding cerumen, granulation tissue, or pus, thereby making the diagnosis more challenging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Cerumen impaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerumen impaction itself is a fairly common cause of ear discomfort, though intense pain is uncommon. Often, patients complain of ear fullness or hearing impairment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12823?source=see_link\">",
"     \"Cerumen\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Tumor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, tumors of the external auditory canal can occur and may present with ear pain. Rhabdomyosarcoma, lymphoma, and eosinophilic granuloma have been reported. These cases may involve a granulomatous mass in the external auditory canal and bloody or serosanguineous discharge. Patients that appear to have a relapsing or unremitting case of otitis externa or perforated otitis media should be evaluated for the possibility of a tumor in the ear canal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18327?source=see_link&amp;anchor=H4#H4\">",
"     \"Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging\", section on 'Head and neck'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Middle and inner ear",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Acute otitis media (AOM)",
"    </span>",
"    &nbsp;&mdash;&nbsp;AOM remains the most common illness diagnosed by pediatricians [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/5\">",
"     5",
"    </a>",
"    ]. In AOM, ear pain, which at times can be quite severe, is typically felt deep within the ear. Often, the pain is worse when the patient is supine. Nasal congestion and cough typically precede the ear pain by several days. Fever occurs in some cases. In younger patients nonspecific symptoms, such as fussiness or irritability, disturbed sleep, and poor feeding may predominate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On otoscopic examination, patients with acute otitis media have evidence of middle ear effusion, with a TM that is bulging or has decreased mobility. The TM may appear cloudy or opaque, with a white, yellow, or occasionally green color reflecting pus behind the TM. An air fluid level may be seen. In some cases the TM may have focal bullae. The TM usually also has focal or diffuse areas of redness, injection, or hemorrhage which should be distinguished from the milder pink flush often seen with fever or crying. The external ear examination is typically normal, with no redness or tenderness, and no adjacent lymphadenopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H19#H19\">",
"     \"Acute otitis media in children: Diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Myringitis refers to inflammation of the TM, with or without associated middle ear fluid. In cases of isolated myringitis, redness or bullae of the TM may be noted in the absence of apparent fluid in the middle ear. Myringitis may be caused by trauma or infection. Bacterial pathogens are most commonly implicated, but viruses may play a role. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H25#H25\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Bullous myringitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Complications of AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H27#H27\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Complications and sequelae'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Spontaneous rupture of the tympanic membrane (TM)",
"      </strong>",
"      &ndash; Suppurative TM perforation is a common complication of AOM, resulting from the accumulation of pus under pressure in the middle ear. Typically, the patient reports ear pain followed by otorrhea, which may be quite copious. On physical examination, a thin, watery, and sometimes foul-smelling fluid is usually observed. In many cases, it may be impossible to visualize the TM. Purulent otorrhea may also be seen in patients who have otitis media in the setting of prior tympanostomy tube placement. In these patients, pathogens may include the typical middle ear bacteria, Staphylococcus aureus or Pseudomonas aeruginosa, which presumably migrate inward from the external ear.",
"     </li>",
"     <li>",
"      <strong>",
"       Mastoiditis",
"      </strong>",
"      &ndash; Mastoiditis occurs when the mastoid air cells, which connect directly to the middle ear space, become infected as a result of adjacent AOM. Clinical findings include pain, swelling, tenderness, and redness over the mastoid region, protrusion of the ear, fever, and toxicity. The diagnosis can be confirmed by CT scan. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/16/5385?source=see_link\">",
"       \"Acute mastoiditis in children: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Facial palsy",
"      </strong>",
"      &ndash; Dysfunction of cranial nerve VII is a rare complication of AOM, probably resulting from inflammation or stretching of the nerve as it passes through the middle ear space [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/6\">",
"       6",
"      </a>",
"      ]. On physical examination, limited ability to close the ipsilateral eye, limited ability to raise the eyebrows, flattening of the nasolabial fold, or asymmetric smile may be noted. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=see_link&amp;anchor=H5#H5\">",
"       \"Facial nerve palsy in children\", section on 'Otitis media'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Inner ear infection",
"      </strong>",
"      &ndash; Labyrinthitis or petrositis are also rare complications of AOM, resulting from contiguous spread of infection. Sensorineural hearing loss, tinnitus, or vertigo may occur. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32472?source=see_link&amp;anchor=H11#H11\">",
"       \"Approach to the child with acute ataxia\", section on 'Labyrinthitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Involvement of contiguous structures",
"      </strong>",
"      &ndash; AOM rarely seeds contiguous structures, such as the meninges",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the brain, causing brain, epidural, or subdural abscess or meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/7\">",
"       7",
"      </a>",
"      ]. Fever, headache, meningismus, ill appearance, altered mental status or focal neurologic findings may result. Alternatively, the infection may remain confined to the middle ear, but inflammatory mediators incite a thrombosis of the adjacent sigmoid",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      lateral sinuses (\"otitic hydrocephalus\"). Diagnosis is confirmed by brain imaging (brain abscess, venous sinus thrombosis) or lumbar puncture (meningitis) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/8,9\">",
"       8,9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Otitis media with effusion (OME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;OME refers to fluid in the middle ear space without acute inflammation. Middle ear fluid typically accumulates as a result of Eustachian tube dysfunction, which itself usually results from nasal infection or allergy. Some patients with OME are asymptomatic, but others have mild ear pain. Feelings of ear fullness or decreased hearing are common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link&amp;anchor=H5#H5\">",
"     \"Otitis media with effusion (serous otitis media) in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hallmark of OME on physical examination is poor or absent mobility of the TM. Bulging of the TM is less common than with acute otitis media. The TM may be mildly full, in neutral position, or even retracted, indicating negative pressure in the middle ear space. The TM may appear amber and translucent (indicating true serous fluid) or mildly white or yellow and cloudy. In some cases of clear, colorless effusions, the presence of bubbles (indicating air trapped within the fluid collection) may be the only sign of effusion. Redness of the TM is not expected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link&amp;anchor=H9#H9\">",
"     \"Otitis media with effusion (serous otitis media) in children\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Cholesteatoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholesteatoma is a rare but serious complication of chronic OME, in which a benign mass of epithelial tissue develops in or behind the tympanic membrane (TM) and can erode into the bone of the ear canal. Permanent hearing deficits may result. The cholesteatoma may present with ear pain or a sense of ear fullness. Physical examination will reveal the presence of a red or yellow mass typically involving the posterior aspect of the TM (",
"    <a class=\"graphic graphic_picture graphicRef76079 \" href=\"UTD.htm?6/8/6272\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef55060 \" href=\"UTD.htm?24/52/25423\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"     \"Cholesteatoma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Traumatic tympanic membrane (TM) perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic perforation of the TM may occur because of penetrating objects (ie, a stick or cotton swab) or because of a wave of air pressure (as when the ear is slapped). In some cases, the perforation will be easily visualized, but in other cases bleeding from the TM may obscure the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19050?source=see_link&amp;anchor=H12#H12\">",
"     \"Etiology of hearing impairment in children\", section on 'TM perforation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Traumatic disruption of the ossicles or inner ear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penetrating or blunt trauma may also lead to traumatic disruption of the ossicles, which may be evident on otoscopy or may be suggested by new onset of severe hearing loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19050?source=see_link&amp;anchor=H13#H13\">",
"     \"Etiology of hearing impairment in children\", section on 'Trauma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Inner ear injury is a rare but serious consequence of barotrauma or blunt trauma. Tinnitus, hearing loss, or vertigo in the setting of trauma should lead the clinician to consider this diagnosis. In some cases, the deficits may be reversible with urgent surgical decompression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19050?source=see_link&amp;anchor=H15#H15\">",
"     \"Etiology of hearing impairment in children\", section on 'Sensorineural'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Hemotympanum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemotympanum is a collection of blood in the middle ear space resulting from blunt trauma (basilar skull fracture) or from barotrauma (altered atmospheric pressure as may occur with air travel or undersea diving) to the middle ear (",
"    <a class=\"graphic graphic_picture graphicRef62387 \" href=\"UTD.htm?31/17/32031\">",
"     picture 3",
"    </a>",
"    ). Rarely, profuse epistaxis will cause hemotympanum by reflux of blood from the nares into the middle ear via the eustachian tube. On examination, the TM has a purple or red color and may be full or bulging. If blood accumulates under sufficient pressure in the middle ear, the TM may rupture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4633?source=see_link&amp;anchor=H7#H7\">",
"     \"Complications of scuba diving\", section on 'Ear barotrauma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=see_link&amp;anchor=H23#H23\">",
"     \"Skull fractures in children\", section on 'Basilar skull fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Basilar skull fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the skull base, which may result from blunt trauma to the ear region, can present with ear pain. Physical findings may include swelling, ecchymosis, or tenderness overlying the mastoid bone (Battle sign), tenderness and swelling in the temporal region, and facial nerve palsy. Hemotympanum or rupture of the TM, with bloody or CSF otorrhea, may occur. Periorbital ecchymoses or CSF rhinorrhea may also be present (",
"    <a class=\"graphic graphic_picture graphicRef69662 \" href=\"UTD.htm?15/54/16237\">",
"     picture 4",
"    </a>",
"    ). If there is associated intracranial injury, altered mental status, headache, vomiting, or focal neurologic findings may occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=see_link&amp;anchor=H23#H23\">",
"     \"Skull fractures in children\", section on 'Basilar skull fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Secondary otalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some cases of apparent ear pain stem from inflammation of nearby structures [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/10\">",
"     10",
"    </a>",
"    ]. These cases will be distinguished by the absence of findings in the ear itself and by the findings of inflammation or injury to adjacent structures. The referred pain arises from nerves that partially innervate the auricle or external auditory canal and include spinal nerves C2 and C3 and cranial nerves V, VII, IX, and X.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Auricular lymphadenopathy or lymphadenitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preauricular lymph nodes may become enlarged in response to ocular processes (most commonly, conjunctivitis) or parotid disorders (parotitis, or rarely malignancy). Postauricular nodes typically become enlarged in response to conditions involving the external ear, the skin overlying the mastoid region, or Epstein Barr virus infection (infectious mononucleosis). Acutely infected nodes are tender, with overlying redness, and occasionally fluctuance. Benign reactive nodes are typically less tender, with no fluctuance and no overlying redness. Malignancy is rare, but should be considered with very large or especially hard, nontender nodes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=see_link\">",
"     \"Diagnostic approach to and initial treatment of cervical lymphadenitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Parotitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parotid gland disorders cause pain just inferior to the ear. On examination, swelling and tenderness of this region will be evident, occasionally with overlying redness. Because of swelling of the isthmus of the parotid gland, the underlying bony angle of the mandible often cannot be distinctly palpated.",
"   </p>",
"   <p>",
"    Most parotid infections in children result from viral infection (eg, mumps, parainfluenza, influenza A, enteroviruses) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/11\">",
"     11",
"    </a>",
"    ]. In these patients, parotid swelling is often bilateral. Bacterial parotitis caused by S. aureus is infrequent. This infection presents with high fever accompanied by unilateral parotid swelling with erythema, marked tenderness of the parotid gland, and pus expressed from Stensen's duct with parotid massage [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/12\">",
"     12",
"    </a>",
"    ]. Parotid swelling is common in patients with HIV, but true HIV parotitis is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Temporal mandibular joint (TMJ) dysfunction syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysfunction of the temporal mandibular joint (TMJ) is fairly common in children over 10 years of age, but rare in younger children. Careful examination will reveal that the pain emanates from the TMJ, and not from the ear itself. Pain is often exacerbated by full opening of the mouth or by clenching of the teeth. Palpation of the TMJ region may reveal tenderness, or a palpable clicking sensation with joint motion. (See",
"    <a class=\"medical medical_review\" href=\"./temporomandibular-disorders-in-adults?source=see_link\">",
"     \"Temporomandibular disorders in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Facial nerve (Bells) palsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;While facial nerve palsy can be a complication of otic processes, such as otitis media or malignant otitis externa, primary facial nerve palsy may itself cause otalgia. Because the facial nerve provides sensation to a region of skin adjacent to the ear, inflammation of the seventh cranial nerve may present with vaguely localized pain in this area. Typically, weakness of the ipsilateral face will be present and will lead to the correct diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=see_link\">",
"     \"Facial nerve palsy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Oropharyngeal infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections or inflammation of the soft palate (such as with coxsackie virus infection or aphthous stomatitis), inflammation of the posterior teeth or gingivae (ie, dental abscess or pericoronitis), or tonsillar infections may present with ear pain. Findings typically include an absence of tenderness or palpable abnormalities of the external ear, a normal middle ear examination, and abnormal findings in the mouth or throat. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39415?source=see_link\">",
"     \"Evaluation of sore throat in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30216?source=see_link&amp;anchor=H21#H21\">",
"     \"Soft tissue lesions of the oral cavity in children\", section on 'Infections'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Sinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinus infection, especially the maxillary sinuses, may cause earache referred through the sensory pathways of the fifth cranial nerve (trigeminal nerve). The cardinal clinical features are nasal symptoms (anterior or posterior nasal discharge, obstruction,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    congestion), cough, or both for more than 10, but less than 30 days that are not improving. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H9#H9\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Acute bacterial rhinosinusitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Cervical spine injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical spine trauma with bony or soft tissue involvement may radiate or, rarely, be referred to the ear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=see_link\">",
"     \"Evaluation of cervical spine injuries in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important questions to ask in the history of a patient with ear pain include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Age",
"      </strong>",
"      &ndash; In infants and toddlers, most cases of ear pain result from middle ear disease. In older children and adolescents, a larger proportion of cases stem from otitis externa, throat infections, or temporomandibular joint disease.",
"     </li>",
"     <li>",
"      <strong>",
"       Blunt or penetrating trauma",
"      </strong>",
"      &ndash; The timing and mechanism of injury should be elicited. Follow-up questions should determine the presence of altered mental status, headache, nausea, vomiting, focal neurologic complaints, or seizures, all of which may suggest intracranial injury. The clinician should also inquire about bloody or clear otorrhea which may indicate traumatic disruption of the tympanic membrane and an associated basilar skull fracture.",
"     </li>",
"     <li>",
"      <strong>",
"       Fever",
"      </strong>",
"      &ndash; Fever is common in minor illnesses, such as uncomplicated otitis media and upper respiratory infection with associated otitis media with effusion. However, fever may indicate complications, such as mastoiditis, meningitis, brain abscess, or malignant otitis externa. In cases with fever, the clinician should ask follow-up questions regarding the presence of headache, neck stiffness, nausea and vomiting, altered mental status, or severe toxicity which may indicate more serious infections.",
"     </li>",
"     <li>",
"      <strong>",
"       Nasal congestion",
"      </strong>",
"      &ndash; Most cases of middle ear disease (acute otitis media or OME) follow from preceding nasal allergy, infection, or obstruction. In cases with no history of preceding nasal symptoms, middle ear disease becomes substantially less likely [",
"      <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/14\">",
"       14",
"      </a>",
"      ]. The clinician should inquire about the duration, severity and course of the symptoms. Other questions to distinguish the cause of the nasal symptoms may also be appropriate.",
"     </li>",
"     <li>",
"      <strong>",
"       Ear tenderness",
"      </strong>",
"      &ndash; Pain with manipulation of the ear, as when pulling a shirt over the head, strongly suggests a diagnosis of external ear disease, such as otitis externa. External ear pain is not typically present in middle ear disease.",
"     </li>",
"     <li>",
"      <strong>",
"       Hearing loss",
"      </strong>",
"      &ndash; Mild to moderate conductive hearing loss may accompany minor illnesses, such as acute otitis media, otitis media with effusion, or otitis externa. However, more significant hearing loss may indicate cholesteatoma, traumatic disruption of the ossicles, or inner ear disease.",
"     </li>",
"     <li>",
"      <strong>",
"       Ear drainage",
"      </strong>",
"      &ndash; In the absence of trauma, ear drainage stems either from otitis externa or otitis media with perforation or tympanostomy tubes. Typically, the drainage in otitis externa is scant and thicker in consistency, whereas the drainage from otitis media can be quite copious and may be bloody, serosanguineous, purulent, or thin and watery.",
"     </li>",
"     <li>",
"      <strong>",
"       Swimming",
"      </strong>",
"      &ndash; A history of recent swimming makes the diagnosis of otitis externa more likely.",
"     </li>",
"     <li>",
"      <strong>",
"       Minor trauma to the ear",
"      </strong>",
"      &mdash; Bug bites or scratches to the external ear often serve as the nidus for cases of cellulitis. Bug bites also may trigger allergic angioedema of the external ear.",
"     </li>",
"     <li>",
"      <strong>",
"       Barotrauma",
"      </strong>",
"      &ndash; Recent air travel or undersea diving are potential causes for hemotympanum in the absence of external trauma.",
"     </li>",
"     <li>",
"      <strong>",
"       Environmental exposures",
"      </strong>",
"      &ndash; Sunburn, frostbite, or contact allergen exposure (like poison ivy) may be pertinent in cases of auricular inflammation.",
"     </li>",
"     <li>",
"      <strong>",
"       Past medical history",
"      </strong>",
"      &ndash; History of prior ear infections or tympanostomy tube placement increases the likelihood of acute otitis media. Topical medication use may explain the source of external ear eruption. Patients with immune deficiency or other significant illnesses may have earache as a sign of a serious contiguous disease, such as cerebral abscess or meningitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with abnormal vital signs who might in some cases present initially with ear pain may be suffering from serious infection, such as meningitis or sepsis, or serious traumatic injury, such as epidural hematoma. Patients with an abnormal mental status in association with ear pain may again be suffering from brain infection or traumatic injury.",
"   </p>",
"   <p>",
"    For stable patients, the level of discomfort should be assessed. Children with severe cases of otitis media or externa may be holding their ear and crying. Young infants or toddlers may be fussy and difficult to console.",
"   </p>",
"   <p>",
"    If there is any possibility of hearing loss, hearing should be assessed with whispered words for older, cooperative children and with an assessment of sound localization ability in younger children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     External ear",
"    </span>",
"    &nbsp;&mdash;&nbsp;The external ear should be inspected for signs of traumatic injury, such as lacerations, ecchymoses, fluctuant hematomas, or swelling. If trauma is suspected, the temporal and parietal region of the skull should be assessed for deformity or tenderness indicating possible fracture. Signs of basilar skull fracture, such as periorbital ecchymoses (",
"    <a class=\"graphic graphic_picture graphicRef69662 \" href=\"UTD.htm?15/54/16237\">",
"     picture 4",
"    </a>",
"    ) or Battle sign (ecchymosis overlying the mastoid bone) should be sought. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=see_link&amp;anchor=H23#H23\">",
"     \"Skull fractures in children\", section on 'Basilar skull fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of trauma, diffuse redness and swelling of the external ear may indicate infection or local allergic reaction:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Infection will be distinguished by tenderness, more distinct redness of the skin, and induration.",
"     </li>",
"     <li>",
"      Perichondritis is suggested by fluctuant abscesses of the helix with focal sparing of the ear lobe",
"     </li>",
"     <li>",
"      Allergic inflammation usually causes a paler purple hue to the skin and little if any tenderness.",
"     </li>",
"     <li>",
"      Contact dermatitis (like poison ivy) may cause a fine, bumpy, pruritic red rash.",
"     </li>",
"     <li>",
"      Frostbite or sunburn leads to diffuse redness with focal blisters.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Protrusion of the ear from the side of the head is sometimes seen with allergic or infectious inflammation of the pinna but can also be a sign of mastoiditis. Tenderness, discoloration, and swelling over the mastoid process should be ascertained [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H30#H30\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Mastoiditis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pre- or postauricular lymphadenopathy should be noted, as should the presence of any fluctuance and overlying redness or swelling. Inflammation of these lymph nodes may be the primary cause of ear pain or may be seen in cases of external ear infection.",
"   </p>",
"   <p>",
"    The tragus should be palpated, gently at first and then more vigorously to fully exclude tragal tenderness, which is virtually always present in cases of acute otitis externa [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Auditory canal and middle ear",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination of the middle ear by otoscopy is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H8#H8\">",
"     \"Acute otitis media in children: Diagnosis\", section on 'Otoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On otoscopic examination, the examiner should first assess whether the tympanic membrane can be visualized adequately. Whenever possible, cerumen should be removed to permit an unobstructed view of the entire ear canal and tympanic membrane (TM).",
"   </p>",
"   <p>",
"    The ear canal should be examined for redness, flaking, swelling, or thick discharge, all of which may be signs of otitis externa. Ear discharge can also be seen with acute otitis media with tympanic membrane perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/3\">",
"     3",
"    </a>",
"    ]; the drainage is usually more copious and watery than with otitis externa. Additional findings may include the presence of masses, foreign bodies, bullae, or eczematous changes.",
"   </p>",
"   <p>",
"    If the tympanic membrane appears thickened or cloudy, or if air bubbles are evident behind the TM, a middle ear effusion should be suspected. In acute otitis media, the tympanic membrane may have diffuse redness, injection, or focal areas of hemorrhage, which should be distinguished from the generalized pink, flushed appearance of the TM frequently seen in children who have fever or who have been crying. An opaque white, yellow, or green color to the tympanic membrane, without visualization of any bony landmarks, indicates a purulent effusion and is another common finding in acute otitis media. Occasionally, tense pus-filled bullae may be seen in acute otitis media. Redness or bullae of the TM without evident fluid in the middle ear suggests isolated myringitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H17#H17\">",
"     \"Acute otitis media in children: Diagnosis\", section on 'Other findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A TM that bulges laterally towards the examiner indicates that the middle ear is under positive pressure, as with acute otitis media and is the most specific sign of acute otitis media. In contrast, a retracted TM indicates negative pressure in the middle ear space, which is a sign of Eustachian tube dysfunction common in cases of otitis media with effusion. Similarly, with pneumatic otoscopy, decreased movement of the TM upon application of positive pressure indicates middle ear fluid under pressure, while decreased movement with negative pressure suggests Eustachian tube dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H8#H8\">",
"     \"Acute otitis media in children: Diagnosis\", section on 'Otoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Perforations of the tympanic membrane should be noted. If a tympanostomy tube has been inserted, its location and patency should be assessed.",
"   </p>",
"   <p>",
"    In cases of trauma, hemotympanum may be noted. Hemotympanum is characterized by a red or purple effusion which may occupy the entire middle ear space or may appear as an air-fluid level (",
"    <a class=\"graphic graphic_picture graphicRef62387 \" href=\"UTD.htm?31/17/32031\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Sources of secondary otalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The temporomandibular joint (TMJ) should be assessed for tenderness, mobility, pain with movement, clicking, or crepitance with motion. (See",
"    <a class=\"medical medical_review\" href=\"./temporomandibular-disorders-in-adults?source=see_link\">",
"     \"Temporomandibular disorders in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The parotid gland should be evaluated for enlargement, focal masses, tenderness, and loss of the normal mandibular angle. Abnormal discharge or redness of Stensen duct in the intraoral examination may also be seen with purulent parotitis.",
"   </p>",
"   <p>",
"    The oral mucosa, gingivae, teeth, tonsils, and pharynx should be evaluated for abnormalities that indicate stomatitis, dental abscess, tonsillitis, or pharyngitis, all of which may present with pain referred to the ear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39415?source=see_link\">",
"     \"Evaluation of sore throat in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30216?source=see_link&amp;anchor=H21#H21\">",
"     \"Soft tissue lesions of the oral cavity in children\", section on 'Infections'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sinus tap tenderness, transillumination, and copious green nasal discharge are insensitive signs of sinusitis but are suggestive when present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H7#H7\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The neck examination should include an assessment for adenopathy, swelling, or masses that may indicate infection or other processes near the ear which may present with ear pain, such as neck trauma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=see_link\">",
"     \"Diagnostic approach to and initial treatment of cervical lymphadenitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=see_link\">",
"     \"Evaluation of cervical spine injuries in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Finally, neurologic examination should include an assessment of facial nerve function, as facial palsy may present with ear pain as one of the initial manifestations. Vestibular function and nystagmus should be assessed in patients for whom inner ear disease is a possibility. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=see_link\">",
"     \"Facial nerve palsy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most routine cases of ear pain, no ancillary studies are necessary. However, ancillary testing may be appropriate in cases where more serious diagnoses are suspected. Ancillary testing may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Computed tomography (CT) scan of head &ndash; Head CT is indicated in trauma cases if intracranial injury or basilar skull fracture are suspected. Head CT should also be performed to confirm suspected diagnoses of mastoiditis or malignant otitis externa. Head CT precedes LP if meningitis is suspected but signs of increased intracranial pressure or focal intracranial lesions (ie, brain abscess) may be present. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=see_link\">",
"       \"Initial approach to severe traumatic brain injury in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Complete blood count (CBC) and erythrocyte sedimentation rate (ESR) &ndash; CBC and ESR are often elevated in cases of more serious or deep-seated infections, such as mastoiditis, malignant otitis externa, or bacterial meningitis. However, if clinical suspicion is high, normal findings on these tests should not be interpreted as definitive proof that more serious infections are not present.",
"     </li>",
"     <li>",
"      Bacterial or fungal culture of ear drainage &ndash; The spectrum of expected pathogens in external otitis is small. Thus, empiric treatment is usually sufficient and less costly than culture. Cultures are reserved for patients with severe external otitis associated with periauricular cellulitis or fever. Cultures should also be considered in patients who are immunocompromised or who have not responded to treatment within about three days. Most of these patients should be referred to an otolaryngologist. Culture of the purulent material is performed with a very small cotton swab. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link\">",
"       \"External otitis: Pathogenesis, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Blood culture &ndash; If bacteremia is suspected in association with complicated otitis with invasive infection, blood cultures should be obtained.",
"     </li>",
"     <li>",
"      Lumbar puncture &ndash; Patients with signs of meningitis should undergo lumbar puncture as long as findings of increased intracranial pressure or focal neurologic deficits are not present.",
"     </li>",
"     <li>",
"      Audiometry &ndash; Hearing tests are indicated urgently in cases in which traumatic injury to the ossicles or disease of the inner ear is evident. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link&amp;anchor=H9#H9\">",
"       \"Evaluation of hearing impairment in children\", section on 'Formal audiology'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The algorithms here provide an approach to the child with earache (",
"    <a class=\"graphic graphic_algorithm graphicRef78456 \" href=\"UTD.htm?42/24/43406\">",
"     algorithm 1A",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef51680 \" href=\"UTD.htm?31/54/32622\">",
"     algorithm 1B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef77906 \" href=\"UTD.htm?27/47/28414\">",
"     algorithm 1C",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef60379 \" href=\"UTD.htm?25/21/25950\">",
"     algorithm 1D",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     The critically ill patient",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with altered mental status, abnormal vital signs, or other signs of severe illness, evaluation should proceed immediately towards resuscitation, if necessary, and emergency therapy (",
"    <a class=\"graphic graphic_algorithm graphicRef78456 \" href=\"UTD.htm?42/24/43406\">",
"     algorithm 1A",
"    </a>",
"    ). In patients with traumatic injury and altered mental status, basilar skull fracture or intracranial hemorrhage should be suspected. Emergent imaging and neurosurgical consultation are warranted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=see_link&amp;anchor=H14#H14\">",
"     \"Initial approach to severe traumatic brain injury in children\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with otitis media who have altered mental status in conjunction with cardiovascular instability, fever, focal neurologic findings, meningismus,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severe headache, complications, such as venous sinus thrombosis, meningitis, or brain abscess should be suspected. Evaluation should include head CT, lumbar puncture (as long as increased ICP, focal neurologic deficit, and focal central nervous system lesion are not evident), and prompt initiation of antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38104?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of brain abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7594?source=see_link\">",
"     \"Etiology, clinical features, and diagnosis of cerebral venous thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stable patients with earache and facial nerve palsy are likely to have acute otitis media with or without mastoiditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H30#H30\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Mastoiditis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h2\">",
"     Ear pain in the trauma patient",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among stable patients with ear pain, it is useful to consider separately those patients with history or signs of traumatic injury to the ear including blunt, penetrating, and barometric trauma (",
"    <a class=\"graphic graphic_algorithm graphicRef51680 \" href=\"UTD.htm?31/54/32622\">",
"     algorithm 1B",
"    </a>",
"    ). Patients with ear trauma should also be evaluated for traumatic injury to adjacent structures, particularly brain injury, basilar skull fracture, and neck injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=see_link\">",
"     \"Minor head trauma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=see_link\">",
"     \"Evaluation of cervical spine injuries in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Inspection of the external ear identifies simple abrasions or lacerations to the ear canal, external lacerations, and auricular contusion. Lacerations to the external ear that involve the cartilage and perichondrium require a layered repair and may lead to permanent cosmetic deformity. Simple contusions with mild swelling or ecchymosis of the ear can be managed with supportive measures (eg, application of ice, oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    or nonsteroidal antiinflammatory medications) and observation. Auricular hematomas present as fluctuant masses near the superior aspect of the pinna, often in patients with a history of wrestling or boxing. Treatment consists of incision and drainage with the application of a pressure dressing to prevent recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hemotympanum, otorrhea, or tympanic membrane (TM) rupture may indicate direct traumatic perforation of the TM, barotrauma, or basilar skull fracture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4633?source=see_link&amp;anchor=H7#H7\">",
"     \"Complications of scuba diving\", section on 'Ear barotrauma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=see_link&amp;anchor=H23#H23\">",
"     \"Skull fractures in children\", section on 'Basilar skull fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Traumatic hearing loss may indicate a deficit in air conduction because of the accumulation of fluid (usually blood) in the middle ear, traumatic disruption of the ossicles, or inner ear injury, which may occur with basilar skull fracture or barotrauma. New onset of vertigo also suggests inner ear injury. Urgent otolaryngology consultation is appropriate. In most cases, the child should also undergo computed tomography (CT) scan of the head. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19050?source=see_link&amp;anchor=H8#H8\">",
"     \"Etiology of hearing impairment in children\", section on 'Trauma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Atraumatic ear pain",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h3\">",
"     External ear disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with redness, swelling, warmth, and apparent protrusion of the auricle are often suffering from cellulitis, which typically results from insect bites, ear piercing, or minor trauma (",
"    <a class=\"graphic graphic_algorithm graphicRef77906 \" href=\"UTD.htm?27/47/28414\">",
"     algorithm 1C",
"    </a>",
"    ). Cellulitis causes pain, tenderness, and induration, in contrast to local allergic reactions (as with insect bites or poison ivy), which typically cause pruritus but little or no pain and tenderness. Fever is sometimes present with cellulitis but is not a feature of allergic reactions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38391?source=see_link\">",
"     \"An overview of angioedema: Pathogenesis and causes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rare cases of perichondritis can be distinguished from cellulitis by the sparing of the ear lobe (which has no cartilage) or by the presence of focal subperichondrial abscesses. There is usually a history of antecedent blunt trauma or ear piercing. Children with perichondritis may need incision and drainage and are typically admitted to the hospital for intravenous antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32503?source=see_link&amp;anchor=H16#H16\">",
"     \"Other Pseudomonas aeruginosa infections\", section on 'Perichondritis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of redness and swelling of the auricle include sunburn and frostbite, which in most cases will be evident from the history and will frequently involve both ears symmetrically. Minor redness of the ear, especially in the concha, may be seen in cases of otitis externa (see below). However, most cases of simple otitis externa do not lead to swelling or diffuse redness of the auricle. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37671?source=see_link&amp;anchor=H7#H7\">",
"     \"Frostbite\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30136?source=see_link\">",
"     \"Sunburn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with vesicular lesions in the ear canal and pinna, especially with pruritus or burning discomfort to the region, have herpes zoster oticus. In some cases, the pruritus, pain, or sensory abnormalities may precede the development of visible skin lesions by several days, so clinicians should consider the diagnosis in older children with hyperesthetic ear discomfort and no visible lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'Ramsay Hunt syndrome (Herpes zoster oticus)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Finally, some patients with apparent abnormality of the auricle may actually be suffering from mastoiditis (",
"    <a class=\"graphic graphic_algorithm graphicRef60379 \" href=\"UTD.htm?25/21/25950\">",
"     algorithm 1D",
"    </a>",
"    ). In mastoiditis, the inflammation of the mastoid region behind the ear leads the auricle to protrude outward. Typically, however, the tissue of the auricle itself is normal, with no redness, swelling, or tenderness. Examination of the middle ear and the mastoid region will provide additional clues to the diagnosis. (See",
"    <a class=\"local\" href=\"#H37\">",
"     'Auditory canal and middle ear'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h3\">",
"     Tragal motion tenderness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tenderness of the tragus is the hallmark of otitis externa [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/3\">",
"     3",
"    </a>",
"    ]. Redness, discharge, or flaking of the ear canal may be seen, but in some mild cases, tragal tenderness may be the only abnormal finding. Patients with a focal area of redness, swelling, and pain in the ear canal likely have furunculosis. Patients with more severe or deep-seated pain, often with fever, and usually with a history of immunocompromise, should be evaluated for the rare diagnosis of malignant otitis externa [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/4\">",
"     4",
"    </a>",
"    ]. If malignant otitis externa is suspected, CBC, ESR, CT scan of the head, and otolaryngology consultation are warranted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20216?source=see_link\">",
"     \"Malignant (necrotizing) external otitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link&amp;anchor=H5#H5\">",
"     \"Skin abscesses, furuncles, and carbuncles\", section on 'Furuncles and carbuncles'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h3\">",
"     Auditory canal mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;Masses in the ear canal will usually be readily evident on physical examination, although they may at times be obscured by surrounding cerumen. Cerumen impaction itself commonly causes hearing loss or a feeling of ear fullness and may occasionally present as ear pain. Thus, removal of cerumen should be pursued whenever possible to aid in diagnosis and sometimes provide therapeutic relief. Foreign bodies, if present, should be removed. If a foreign body cannot be removed, otolaryngology consultation is indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12823?source=see_link\">",
"     \"Cerumen\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A red or yellow mass in the posterior aspect of the TM may indicate a cholesteatoma, especially if there is an antecedent history of chronic OME. Rarely, cases of malignancy may present similarly. Granulomas of the ear canal may sometimes be an inflammatory reaction to the chronic presence of a foreign body. In other cases, a mass of the wall of the ear canal may indicate a more serious diagnosis, such as eosinophilic granuloma or rhabdomyosarcoma. If the diagnosis is uncertain, otolaryngology consultation is indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"     \"Cholesteatoma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18327?source=see_link&amp;anchor=H4#H4\">",
"     \"Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging\", section on 'Head and neck'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other diseases of the ear canal typically cause more pruritus than pain. Redness, flaking, and scaliness of the ear canal may indicate eczema, especially if the symptoms are chronic or recurring. Contact dermatitis of the ear canal often follows from the use of topical antibiotics or anesthetic drops and may present with a pink-red bumpy rash in the ear canal and on the adjacent skin of the concha. Fungal otitis externa should also be considered, especially if the symptoms have a relatively recent onset and if there is a prior history of topical antibiotic use. In cases of fungal otitis externa, there may be an abnormal odor",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    discharge in the canal. Culture of the discharge will aid in the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link&amp;anchor=H21#H21\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\", section on 'Otomycosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26104?source=see_link\">",
"     \"Contact dermatitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with pain of the external ear and none of the above findings should be evaluated for middle ear disease (",
"    <a class=\"graphic graphic_algorithm graphicRef60379 \" href=\"UTD.htm?25/21/25950\">",
"     algorithm 1D",
"    </a>",
"    ) and for causes of secondary otalgia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h3\">",
"     Middle ear disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with ear pain have acute otitis media (AOM) (",
"    <a class=\"graphic graphic_algorithm graphicRef60379 \" href=\"UTD.htm?25/21/25950\">",
"     algorithm 1D",
"    </a>",
"    ). On physical examination, these patients have a visible abnormality of the tympanic membrane",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    discharge from the middle ear. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Middle and inner ear'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with middle ear disease, pain, swelling, tenderness,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    discoloration of the mastoid region indicate likely mastoiditis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/15\">",
"     15",
"    </a>",
"    ]. With mastoiditis, the auricle may protrude outward but should appear uninflamed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H30#H30\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Mastoiditis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Facial nerve palsy can sometimes result from serious cases of otitis media or mastoiditis (",
"    <a class=\"graphic graphic_algorithm graphicRef78456 \" href=\"UTD.htm?42/24/43406\">",
"     algorithm 1A",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/6\">",
"     6",
"    </a>",
"    ]. Other cases of otitis media may be associated with inner ear dysfunction, presenting as severe hearing loss or vertigo [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/6\">",
"     6",
"    </a>",
"    ]. In cases of otitis media associated with facial nerve or inner ear dysfunction, otolaryngology consultation should be pursued to consider possible surgical intervention. Computed tomography (CT) of the head may be performed to assess for associated mastoiditis, cranial, or intracranial extension of the infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=see_link&amp;anchor=H5#H5\">",
"     \"Facial nerve palsy in children\", section on 'Otitis media'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with otorrhea have usually experienced spontaneous rupture of the tympanic membrane as a complication of acute otitis media. Otorrhea commonly occurs also in patients with tympanostomy tubes and acute otitis media. Occasionally, culture of the fluid may help in guiding antibiotic therapy, although empiric therapy is usually sufficient. Typically, the copious amount and thin consistency of the draining fluid, the absence of tragal tenderness, and a history of preceding nasal symptoms distinguish the otorrhea of otitis media from the discharge sometimes seen in otitis externa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H29#H29\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'TM perforation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with bulging or impaired mobility of the TM or an air-fluid level have middle ear effusion. (See",
"    <a class=\"local\" href=\"#H37\">",
"     'Auditory canal and middle ear'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Some patients may have visible abnormality of the TM but with no evidence of fluid in the middle ear. Redness or bullae of the TM indicate myringitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H25#H25\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Bullous myringitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with no visible abnormality of the TM may have secondary otalgia or psychogenic disease, but these patients may be suffering from Eustachian tube dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/47/13050/abstract/10\">",
"     10",
"    </a>",
"    ]. Eustachian tube dysfunction usually results from nasal disease (viral respiratory infection, nasal allergy, adenoid hypertrophy, or sinusitis) and can lead to painful pressure disturbances in the middle ear. Although Eustachian tube dysfunction is typically associated with middle ear effusion and abnormal mobility of the TM (ie, otitis media with effusion), in some cases, physical examination may be essentially normal. Eustachian tube dysfunction is an unlikely explanation for ear pain in patients without a history of recent nasal symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link&amp;anchor=H5#H5\">",
"     \"Otitis media with effusion (serous otitis media) in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48\">",
"    <span class=\"h2\">",
"     Secondary causes of otalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attention should be given to anatomic regions that are known for causing referred ear pain (see",
"    <a class=\"local\" href=\"#H26\">",
"     'Secondary otalgia'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parotid region, evaluating for parotid swelling and tenderness or loss of the mandibular angle that indicate parotitis.",
"     </li>",
"     <li>",
"      Pre- and postauricular lymph nodes, looking for primary lymphadenitis, conjunctivitis, skin infections behind the ear, or signs of Epstein Barr virus infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=see_link\">",
"       \"Diagnostic approach to and initial treatment of cervical lymphadenitis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Temporomandibular joint (TMJ), assessing for tenderness, crepitance, or pain with motion that suggest TMJ dysfunction syndrome. (See",
"      <a class=\"medical medical_review\" href=\"./temporomandibular-disorders-in-adults?source=see_link\">",
"       \"Temporomandibular disorders in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Facial nerve disease (ie, Bell's palsy), suggesting sensory symptoms of pain adjacent to the ear. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=see_link\">",
"       \"Facial nerve palsy in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Oropharyngeal lesions, including dental abscess, suppurative pharyngitis, and stomatitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39415?source=see_link\">",
"       \"Evaluation of sore throat in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30216?source=see_link&amp;anchor=H21#H21\">",
"       \"Soft tissue lesions of the oral cavity in children\", section on 'Infections'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Prolonged purulent nasal drainage or maxillary sinus tenderness, indicating sinusitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H9#H9\">",
"       \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Acute bacterial rhinosinusitis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Finally, the possibility of psychogenic pain or malingering should also be considered if no clinical findings suggest an alternative diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/2/15394?source=see_link\">",
"       \"Patient information: Outer ear infection (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26816?source=see_link\">",
"       \"Patient information: External otitis (including swimmer's ear) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a child with earache, assessment for ill appearance, trauma, and anatomic region of abnormality guide the approach (",
"    <a class=\"graphic graphic_algorithm graphicRef78456 graphicRef51680 graphicRef77906 graphicRef60379 \" href=\"UTD.htm?0/2/45\">",
"     algorithm 1A-D",
"    </a>",
"    ). The differential diagnosis of ear pain is best categorized by the anatomic site from which the pain originates (",
"    <a class=\"graphic graphic_table graphicRef60554 \" href=\"UTD.htm?29/11/29885\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/1\">",
"      Ghanem T, Rasamny JK, Park SS. Rethinking auricular trauma. Laryngoscope 2005; 115:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/2\">",
"      Kansu L, Yilmaz I. Herpes zoster oticus (Ramsay Hunt syndrome) in children: case report and literature review. Int J Pediatr Otorhinolaryngol 2012; 76:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/3\">",
"      Rosenfeld RM, Brown L, Cannon CR, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg 2006; 134:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/4\">",
"      Rubin J, Yu VL, Stool SE. Malignant external otitis in children. J Pediatr 1988; 113:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/5\">",
"      American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/6\">",
"      Hyd&eacute;n D, Akerlind B, Peebo M. Inner ear and facial nerve complications of acute otitis media with focus on bacteriology and virology. Acta Otolaryngol 2006; 126:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/7\">",
"      Wu JF, Jin Z, Yang JM, et al. Extracranial and intracranial complications of otitis media: 22-year clinical experience and analysis. Acta Otolaryngol 2012; 132:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/8\">",
"      Hafidh MA, Keogh I, Walsh RM, et al. Otogenic intracranial complications. a 7-year retrospective review. Am J Otolaryngol 2006; 27:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/9\">",
"      Zapalac JS, Billings KR, Schwade ND, Roland PS. Suppurative complications of acute otitis media in the era of antibiotic resistance. Arch Otolaryngol Head Neck Surg 2002; 128:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/10\">",
"      Shah RK, Blevins NH. Otalgia. Otolaryngol Clin North Am 2003; 36:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/11\">",
"      Battle S, Laudenbach J, Maguire JH. Influenza parotitis: a case from the 2004 to 2005 vaccine shortage. Am J Med Sci 2007; 333:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/12\">",
"      Brook I. Acute bacterial suppurative parotitis: microbiology and management. J Craniofac Surg 2003; 14:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/13\">",
"      Dave SP, Pernas FG, Roy S. The benign lymphoepithelial cyst and a classification system for lymphocytic parotid gland enlargement in the pediatric HIV population. Laryngoscope 2007; 117:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/14\">",
"      Heikkinen T, Ruuskanen O. Signs and symptoms predicting acute otitis media. Arch Pediatr Adolesc Med 1995; 149:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/15\">",
"      Katz A, Leibovitz E, Greenberg D, et al. Acute mastoiditis in Southern Israel: a twelve year retrospective study (1990 through 2001). Pediatr Infect Dis J 2003; 22:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/47/13050/abstract/16\">",
"      Palmu AA, Kotikoski MJ, Kaijalainen TH, Puhakka HJ. Bacterial etiology of acute myringitis in children less than two years of age. Pediatr Infect Dis J 2001; 20:607.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6439 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-09F22AFDA5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13050=[""].join("\n");
var outline_f12_47_13050=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H49\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Auricle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Contusion (auricular hematoma)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Cellulitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Herpes zoster oticus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Allergic angioedema",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Environmental injuries to the ear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ear canal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Otitis externa",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Malignant otitis externa",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Furuncle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Foreign body",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Cerumen impaction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Middle and inner ear",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Acute otitis media (AOM)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Complications of AOM",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Otitis media with effusion (OME)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Cholesteatoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Traumatic tympanic membrane (TM) perforation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Traumatic disruption of the ossicles or inner ear",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Hemotympanum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Basilar skull fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Secondary otalgia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Auricular lymphadenopathy or lymphadenitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Parotitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Temporal mandibular joint (TMJ) dysfunction syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Facial nerve (Bells) palsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Oropharyngeal infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Sinusitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Cervical spine injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      External ear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Auditory canal and middle ear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Sources of secondary otalgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      The critically ill patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      Ear pain in the trauma patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Atraumatic ear pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      - External ear disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      - Tragal motion tenderness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      - Auditory canal mass",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      - Middle ear disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H48\">",
"      Secondary causes of otalgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H49\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6439\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6439|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?42/24/43406\" title=\"algorithm 1A\">",
"      Emergent ear pain in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?31/54/32622\" title=\"algorithm 1B\">",
"      Traumatic ear pain in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?27/47/28414\" title=\"algorithm 1C\">",
"      External ear pediatric algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?25/21/25950\" title=\"algorithm 1D\">",
"      Middle ear causes otalgia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6439|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/8/6272\" title=\"picture 1\">",
"      Cholesteatoma pars flaccida",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/52/25423\" title=\"picture 2\">",
"      Cholesteatoma tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/17/32031\" title=\"picture 3\">",
"      Traumatic hemotympanum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/54/16237\" title=\"picture 4\">",
"      Raccoon eyes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6439|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/11/29885\" title=\"table 1\">",
"      Causes pediatric earache",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=related_link\">",
"      Acute bacterial rhinosinusitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/16/5385?source=related_link\">",
"      Acute mastoiditis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=related_link\">",
"      Acute otitis media in children: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15641?source=related_link\">",
"      An overview of angioedema: Clinical features, diagnosis, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38391?source=related_link\">",
"      An overview of angioedema: Pathogenesis and causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32472?source=related_link\">",
"      Approach to the child with acute ataxia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12823?source=related_link\">",
"      Cerumen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=related_link\">",
"      Cholesteatoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4633?source=related_link\">",
"      Complications of scuba diving",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26104?source=related_link\">",
"      Contact dermatitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=related_link\">",
"      Diagnostic approach to and initial treatment of cervical lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19050?source=related_link\">",
"      Etiology of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7594?source=related_link\">",
"      Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=related_link\">",
"      Evaluation of cervical spine injuries in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39415?source=related_link\">",
"      Evaluation of sore throat in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=related_link\">",
"      External otitis: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=related_link\">",
"      Facial nerve palsy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37671?source=related_link\">",
"      Frostbite",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=related_link\">",
"      Initial approach to severe traumatic brain injury in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20216?source=related_link\">",
"      Malignant (necrotizing) external otitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=related_link\">",
"      Minor head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32503?source=related_link\">",
"      Other Pseudomonas aeruginosa infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=related_link\">",
"      Otitis media with effusion (serous otitis media) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38104?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26816?source=related_link\">",
"      Patient information: External otitis (including swimmer's ear) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/2/15394?source=related_link\">",
"      Patient information: Outer ear infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18327?source=related_link\">",
"      Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=related_link\">",
"      Skin abscesses, furuncles, and carbuncles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=related_link\">",
"      Skull fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30216?source=related_link\">",
"      Soft tissue lesions of the oral cavity in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30136?source=related_link\">",
"      Sunburn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./temporomandibular-disorders-in-adults?source=related_link\">",
"      Temporomandibular disorders in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_47_13051="IDUS vs ERCP EUS ERP panc ca";
var content_f12_47_13051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sensitivity and specificity of intraductal ultrasound (IDUS), endoscopic ultrasound (EUS), computed tomographic (CT) scanning, and endoscopic retrograde pancreatography (ERP) in the diagnosis of pancreatic cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        IDUS (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        EUS (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        CT (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        ERP (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Sensitivity",
"        </strong>",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Specificity",
"        </strong>",
"       </td>",
"       <td>",
"        92",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        64",
"       </td>",
"       <td>",
"        64",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Furukawa T, Oohashi K, Yamao K, et al. Endoscopy 1997; 29:561.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13051=[""].join("\n");
var outline_f12_47_13051=null;
var title_f12_47_13052="Secondary causes of osteoporosis in premenopausal women";
var content_f12_47_13052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F64403&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F64403&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Secondary causes of osteoporosis in premenopausal women",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Anorexia nervosa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal malabsorption (eg, celiac disease, postoperative states)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin D and/or calcium deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperparathyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cushing's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypogonadism (hypogonadotropic or hypergonadotropic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypercalciuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatoid arthritis and other inflammatory conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcoholism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liver disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osteogenesis imperfecta",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic mastocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marfan's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Homocystinuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Immunosuppressants (cyclosporine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Antiseizure medications (particularly phenobarbital and phenytoin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        GnRH agonists (when used to suppress ovulation)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Heparin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cancer chemotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Possible contributors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Excess thyroid hormone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Depot medroxyprogesterone acetate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Depression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Thiazolidinediones",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carolyn Becker, MD and Adi Cohen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13052=[""].join("\n");
var outline_f12_47_13052=null;
var title_f12_47_13053="Causes intractable hiccups";
var content_f12_47_13053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F82395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F82395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of persistent and intractable hiccups",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Central nervous system disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Vascular",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Ischemic/hemorrhagic stroke*, AV malformations, temporal arteritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Encephalitis*, meningitis, brain abscess, neurosyphillis, subphrenic abscess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Structural",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Head trauma*, intracranial neoplasms, brainstem neoplasms, multiple sclerosis, syringomyelia, hydrocephalus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Vagus and phrenic nerve irritation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Goiter*, pharyngitis*, laryngitis, hair or foreign body irritation of tympanic membrane, neck cyst or other tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Gastrointestinal disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gastric distention, gastritis, peptic ulcer disease, pancreatitis, pancreatic cancer, gastric carcinoma, abdominal abscesses, gallbladder disease, inflammatory bowel disease, hepatitis, aerophagia, esophagael distention, esophagitis, bowel obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Thoracic disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Enlarged lymph nodes secondary to infection or neoplasm*, pneumonia, empyema, bronchitis, asthma, pleuritis, aortic aneurysm, mediastinitis, mediastinal tumors, chest trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cardiovascular disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myocardial infarction, pericarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Toxic-metabolic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alcohol*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Herpes zoster",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypocalcemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypocapnia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hyponatremia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Influenza",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malaria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tuberculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Uremia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Postoperative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        General anesthesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intubation (stimulation of glottis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neck extension (stretching phrenic nerve roots)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gastric distention",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Traction on viscera",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alpha methyldopa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Short-acting barbituates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chemotherapeutic agents (eg, carboplatin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dexamethasone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diazepam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Psychogenic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anorexia nervosa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Conversion reaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Excitement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malingering",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Schizophrenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Stress",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * More common causes.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13053=[""].join("\n");
var outline_f12_47_13053=null;
var title_f12_47_13054="Use of calcium channel blockers";
var content_f12_47_13054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F51498&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F51498&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Increasing use of longer-acting dihydropyridines",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 410px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Introduction and growth of new prescriptions of differing formulations of nifedipine and of amlodipine since 1986. Nifedipine was only available in the United States as a short-acting formulation in the late 1980s. The slow-release GITS (gastrointestinal therapeutic system) formulation of nifedipine was not introduced until 1989, and its usage did not increase appreciably until 1991-1992; the usage of amlodipine began to increase in 1993.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Epstein, M, Am J Hypertens 1996;9:110.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13054=[""].join("\n");
var outline_f12_47_13054=null;
var title_f12_47_13055="IPEX eczematous skin";
var content_f12_47_13055=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F78215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F78215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eczematous skin lesions in IPEX",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 238px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These eczematous skin lesions (with overlying ointment) were photographed on the back of a young child with IPEX.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Talal Chatila, MD and Melinda Braskett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_47_13055=[""].join("\n");
var outline_f12_47_13055=null;
